<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Anesthesia for patients with acute burn injuries</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Anesthesia for patients with acute burn injuries</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Anesthesia for patients with acute burn injuries</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Hernando Olivar, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Christopher Barnes, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael F O'Connor, MD, FCCM</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nancy A Nussmeier, MD, FAHA</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 11, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H463534900"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Anesthesia providers may be involved in the management of burn patients throughout the perioperative period, including preoperative airway management, early resuscitation, intraoperative anesthetic care, postoperative intensive care, management of postoperative pain, and subsequent scar revisions. This topic reviews these aspects of the anesthetic management of burn patients. Other issues encountered during management of burn patients are reviewed separately. (See  <a class="medical medical_review" href="/d/html/16320.html" rel="external">"Overview of the management of the severely burned patient"</a> and  <a class="medical medical_review" href="/d/html/350.html" rel="external">"Emergency care of moderate and severe thermal burns in adults"</a> and  <a class="medical medical_review" href="/d/html/349.html" rel="external">"Treatment of minor thermal burns"</a>.)</p><p class="headingAnchor" id="H463534906"><span class="h1">PREANESTHETIC ASSESSMENT</span></p><p class="headingAnchor" id="H187677677"><span class="h2">Note estimated burn extent and severity</span><span class="headingEndMark"> — </span>Major burns (eg, full-thickness burns involving &gt;10 percent total body surface area [TBSA] or partial-thickness burn of &gt;25 percent TBSA  (<a class="graphic graphic_figure graphicRef71190" href="/d/graphic/71190.html" rel="external">figure 1</a>)) cause intense physiologic and inflammatory responses that affect many aspects of anesthetic care (eg, airway management, fluid management, drug dosing, temperature regulation). High-voltage burns, chemical burns, and associated smoke inhalation injury are also defined as major burns. (See  <a class="medical medical_review" href="/d/html/16320.html" rel="external">"Overview of the management of the severely burned patient"</a> and  <a class="medical medical_review" href="/d/html/819.html" rel="external">"Assessment and classification of burn injury"</a>.)</p><p class="headingAnchor" id="H3814735647"><span class="h2">Assess the airway</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute burn injury </strong>–<strong> </strong>Assess the airway for signs of possible difficulty with laryngoscopy due to oropharyngeal tissue injury or edema and/or signs of probable inhalation injury. Signs include burns around the mouth, deep facial or neck burns, singed facial hair, or within the nares, blistering or edema of the oropharynx, persistent cough or wheezing, carbonaceous sputum, or abnormalities in arterial blood gases (ie, hypoxia or hypercapnia). Stridor, hoarseness, muffled speech, or dysphagia indicate impending airway obstruction and an urgent need for endotracheal intubation. Notably, ongoing fluid resuscitation may exacerbate laryngeal swelling. Once massive edema of the airway has developed, emergency intubation may be extremely difficult. (See  <a class="medical medical_review" href="/d/html/350.html" rel="external">"Emergency care of moderate and severe thermal burns in adults", section on 'Airway management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Subsequent procedures </strong>– Even after initial resuscitation for a burn injury, mouth opening and neck mobility may be restricted due to pain, edema, burn eschars, bolster dressing or neck braces, or more chronically, scar contractures  (<a class="graphic graphic_table graphicRef94433" href="/d/graphic/94433.html" rel="external">table 1</a>). Tense edema in the submandibular space can limit displacement of the tongue, making laryngoscopy difficult. A tongue depressor or laryngoscope blade may be used to evaluate the degree of mouth-opening and appearance of the oropharyngeal tissue. A mouth opening of less than 4 cm is a predictor of difficult intubation using direct laryngoscopy, similar to patients with neck braces or patients in a c-collar who may have limited mouth opening. In such cases, video laryngoscopy is often the preferred intubation technique [<a href="#rid1">1,2</a>].</p><p></p><p class="headingAnchor" id="H463534921"><span class="h2">Assess cardiovascular status</span><span class="headingEndMark"> — </span>(See  <a class="medical medical_review" href="/d/html/87444.html" rel="external">"Overview of complications of severe burn injury", section on 'Cardiac failure'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Low cardiac output "ebb," phase (resuscitative phase) </strong>– In the first 48 hours after a major burn, cardiac output (CO) is reduced up to 60 percent from baseline due to hypovolemia from permeability-induced plasma loss, reduced myocardial response to catecholamines, increased systemic vascular resistance due to elevated vasopressin levels, depressed myocardial contractility, and possible myocardial ischemia due to decreased coronary blood flow [<a href="#rid3">3-6</a>]. The large volumes that these patients require can sometimes result in over-resuscitation, leading to pulmonary edema and right heart failure [<a href="#rid7">7</a>]. (See <a class="local">'Assess intravascular volume status'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>High cardiac output "flow," phase (recovery phase) </strong>– During the recovery phase 72 to 96 hours postburn, hyperdynamic and hypermetabolic responses result in increased CO, tachycardia, increased myocardial oxygen consumption, and decreased systemic vascular resistance [<a href="#rid4">4</a>]. Elevation of catecholamines in major burns produces hyperdynamic circulation, augments energy expenditure and increases catabolism in skeletal muscle. Nonselective beta blocker therapy is sometimes used to block catecholamine receptors, treat cardiac dysfunction, and modulate the hyperdynamic response during this phase [<a href="#rid8">8,9</a>].</p><p></p><p class="headingAnchor" id="H894619087"><span class="h2">Assess intravascular volume status</span><span class="headingEndMark"> — </span>During the resuscitative or "ebb phase," in the first 48 hours after burn injury, a systemic inflammatory response causes increased capillary permeability which in turn causes loss of plasma fluid, electrolytes, and proteins [<a href="#rid4">4,10,11</a>]. Effective preoperative fluid resuscitation is guided by formulas (eg, the American Burn Association [ABA] formula) targeted to achieve ABA-recommended urine output of 0.5 to 1.0 mL/kg per hour as the resuscitative endpoint [<a href="#rid12">12,13</a>]. Therapeutic perioperative plasma exchange to remove inflammatory mediators has been used in selected patients who have signs of failed resuscitation despite appropriate fluid administration [<a href="#rid14">14</a>]. (See  <a class="medical medical_review" href="/d/html/350.html" rel="external">"Emergency care of moderate and severe thermal burns in adults", section on 'Fluid resuscitation'</a>.)</p><p>Excessive perioperative intravenous (IV) fluid administration (eg, "fluid creep") can increase extravascular lung water causing pulmonary edema, as well as abdominal compartment syndrome and compromised circulation of extremities if burns are circumferential in nature [<a href="#rid14">14-16</a>].</p><p class="headingAnchor" id="H463534929"><span class="h2">Assess for pulmonary abnormalities</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Early pulmonary manifestations</strong> – Burn patients with concomitant smoke inhalation have a higher likelihood of pulmonary complications [<a href="#rid17">17-19</a>]. Singeing of facial or nasal hair, evidence of oropharyngeal carbonaceous deposits, or carboxyhemoglobin (COHb) levels &gt;10 percent predict smoke inhalation injury, which is confirmed using bronchoscopy [<a href="#rid4">4,19,20</a>]. The inflammatory response produced by chemicals in the smoke can induce bronchospasm that may require aggressive bronchodilator treatment [<a href="#rid21">21</a>]. Systemic and respiratory effects of chemicals in smoke (carbon monoxide, cyanide) from the combustion of synthetic fabrics also result in ciliary dysfunction, thickening of secretions with hypoventilation, loss of hypoxic pulmonary vasoconstriction, pulmonary hypertension, atelectasis, and ventilation-perfusion mismatch with increased pulmonary shunting, as discussed in detail elsewhere [<a href="#rid19">19,22</a>]. (See  <a class="medical medical_review" href="/d/html/350.html" rel="external">"Emergency care of moderate and severe thermal burns in adults"</a> and  <a class="medical medical_review" href="/d/html/105477.html" rel="external">"Inhalation injury from heat, smoke, or chemical irritants"</a>.)</p><p></p><p class="bulletIndent1">Aggressive preoperative crystalloid resuscitation during the recovery (flow) phase reduces plasma oncotic pressure and aggravates pulmonary edema which further impairs gas exchange (see <a class="local">'Assess intravascular volume status'</a> above). Pulmonary failure may occur either immediately after burn injury, or several days later, due to progression of the inhalation injury, volume overload, and/or development of acute respiratory distress syndrome (ARDS) [<a href="#rid4">4,23</a>]. (See  <a class="medical medical_review" href="/d/html/87444.html" rel="external">"Overview of complications of severe burn injury", section on 'Pulmonary failure'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other pulmonary considerations</strong> – A restrictive lung defect with impaired ventilation can occur soon after a burn injury of the thorax from severe chest wall edema or eschar formation, notably if the injury is circumferential in nature. Additionally scar contractures of the thorax may also lead to a restrictive lung disease-like pattern [<a href="#rid4">4</a>]. Patients may develop hypoventilation and respiratory failure due to loss of chest wall elasticity and decrease in their effective lung volumes. Intubation and mechanical ventilation may be necessary. Elevated peak inspiratory pressures as a result of circumferential burn injuries may necessitate the need for chest wall escharotomies to improve respiratory mechanics  (<a class="graphic graphic_figure graphicRef79668" href="/d/graphic/79668.html" rel="external">figure 2</a>) [<a href="#rid24">24</a>].</p><p></p><p class="headingAnchor" id="H463534952"><span class="h2">Perioperative nutritional considerations</span><span class="headingEndMark"> — </span>Nutritional supplementation (enteral or parenteral) should be continued throughout the perioperative period in selected severe burn patients to counteract the effects of an elevated catabolic state. Frequently, enteral tube feedings are needed to allow for aggressive nutritional support. Notably, hypermetabolic responses to an injury can persist for up to three years following a severe burn. (See  <a class="medical medical_review" href="/d/html/818.html" rel="external">"Hypermetabolic response to moderate-to-severe burn injury and management"</a>.)</p><p>At our institution, we continue enteral nutrition if the patient is intubated and there is no plan to manipulate the airway during their operative care (ie, tube exchange, tracheostomy placement). This differs from management of most surgical patients who fast before and during surgery (see  <a class="medical medical_review" href="/d/html/15698.html" rel="external">"Preoperative fasting in adults"</a>). The overall goal of nutritional supplementation is to improve long-term outcomes by reducing caloric deficits and the need for exogenous albumin supplementation, as well as by reducing the risk of wound infection [<a href="#rid4">4,25,26</a>]. Intraoperative enteral nutrition for pediatric patients with severe burns may also be associated with survival benefit and decreased mortality in the critically ill [<a href="#rid27">27</a>].</p><p>If continuous nutritional support is not feasible intraoperatively, patients should be vigilantly monitored for the development of hypoglycemia given their profound hypermetabolic state.</p><p class="headingAnchor" id="H3111612138"><span class="h2">Surgical considerations</span><span class="headingEndMark"> — </span>Patients with deep burn wounds typically undergo multiple procedures requiring anesthetic management, whether in the operating room, procedural suite for complex wound care, or at the hospital bedside (eg, escharotomies of circumferential burns upon admission). An understanding of the surgical plan for the current procedure and subsequent planned procedures is necessary.</p><p>Early burn wound excision and skin grafting for wound coverage are crucial aspects of the treatment of thermally injured patients. The burn wound is excised either at a dermal level (eg, tangential excision, for partial-thickness burns) or deep to the subcutaneous tissue (eg, fascial excision, for full-thickness burns), depending on the depth of the burn. Then, the excised areas are covered, ideally with split-thickness skin autografts. When there is insufficient donor skin, other coverage is used (eg, allografts, xenografts, synthetic skin products, and cultured epithelial autografts) [<a href="#rid28">28,29</a>]. Blood loss during burn excision operations can be extensive, published estimates are approximately 3 percent of total blood volume per 1 percent TBSA excised [<a href="#rid4">4</a>]. (See <a class="local">'Transfusion decisions'</a> below and  <a class="medical medical_review" href="/d/html/350.html" rel="external">"Emergency care of moderate and severe thermal burns in adults"</a> and  <a class="medical medical_review" href="/d/html/14990.html" rel="external">"Overview of surgical procedures used in the management of burn injuries"</a>.)</p><p>Subsequent burn dressing changes usually occur at the bedside as part of the spectrum of care for burn injuries. Depending on wound complexity, patient age, and anticipated procedural pain intensity, moderate to deep sedation, regional anesthesia, or occasionally general anesthesia may be necessary for procedures performed outside of the operating room setting [<a href="#rid30">30</a>]. Later, scar revision procedures may be performed at variable timepoints weeks or even years after the original burn injury. (See <a class="local">'Later scar revision procedures'</a> below.)</p><p>In contrast to treatment of patients with deep burn wounds, superficial and small burns (&lt;5 percent TBSA) that do not involve joints or vital organs can generally be treated on an outpatient basis. (See  <a class="medical medical_review" href="/d/html/349.html" rel="external">"Treatment of minor thermal burns"</a>.)</p><p class="headingAnchor" id="H2145614612"><span class="h1">INTRAOPERATIVE MONITORING</span></p><p class="headingAnchor" id="H1877265837"><span class="h2">Standard monitoring considerations</span><span class="headingEndMark"> — </span>Burn patients often present challenges in the use of standard American Society of Anesthesiologists (ASA) monitors [<a href="#rid31">31</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Electrocardiogram </strong>–<strong> </strong>Burns on the torso and upper extremities often prevent adhesive electrocardiogram lead placement. In these cases, needle electrodes or surgical stapling of the electrodes may be necessary.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulse oximetry </strong>–<strong> </strong>Sites for pulse oximeter probe application may be limited in patients with extensive burns to the face, neck, extremities, and/or planned skin graft harvests in unburned extremities. Thus, probes for multiple sites should be immediately available. Also, carboxy-hemoglobinemia in patients with smoke inhalation and carbon monoxide poisoning may falsely elevate pulse oximetry values. In these cases, a co-oximeter may be necessary to obtain an accurate measurement of oxyhemoglobin. (See  <a class="medical medical_review" href="/d/html/1612.html" rel="external">"Pulse oximetry", section on 'Carboxyhemoglobin'</a> and  <a class="medical medical_review" href="/d/html/322.html" rel="external">"Carbon monoxide poisoning", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Noninvasive blood pressure (BP) cuff</strong> – Placement of a noninvasive BP cuff may not be possible in patients with significant edema or generalized burns to the extremities. In these cases, an intra-arterial catheter may be necessary. When no other options are available, the catheter may be placed into burned or newly grafted skin and should be secured with sutures. An intra-arterial catheter provides moment-to-moment measurement of BP and also enables assessment of respiratory variations in the intra-arterial waveform as a dynamic hemodynamic variable to guide fluid therapy  (<a class="graphic graphic_figure graphicRef86275" href="/d/graphic/86275.html" rel="external">figure 3</a> and <a class="graphic graphic_table graphicRef85850" href="/d/graphic/85850.html" rel="external">table 2</a>) [<a href="#rid32">32</a>]. (See <a class="local">'Dynamic hemodynamic parameters'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other standard monitors</strong> – Standard monitors also include temperature probes (eg, esophageal, bladder). The bladder catheter is used to monitor and maintain urine output between 0.5 to 1.0 mL/kg per hour. (See  <a class="medical medical_review" href="/d/html/14942.html" rel="external">"Intraoperative fluid management", section on 'Traditional static parameters'</a>.)</p><p></p><p class="headingAnchor" id="H4270795675"><span class="h2">Dynamic hemodynamic parameters</span><span class="headingEndMark"> — </span>We typically monitor dynamic hemodynamic parameters in patients with severe burn injuries. This may include qualitative visual assessment of intra-arterial waveform  (<a class="graphic graphic_figure graphicRef86275" href="/d/graphic/86275.html" rel="external">figure 3</a>) [<a href="#rid33">33</a>] or the use of a commercially available device to provide automated calculations of respiratory-related variations in systolic BP, pulse pressure (PP), or stroke volume (SV)  (<a class="graphic graphic_table graphicRef85850" href="/d/graphic/85850.html" rel="external">table 2</a>) [<a href="#rid4">4,13,32</a>]. As an alternate monitor, an esophageal Doppler device can also be used to estimate SV and its variations [<a href="#rid34">34</a>]. These devices are used to maintain optimal intravascular volume and guide vasoactive therapy to maintain optimal hemodynamics and fluid administration. (See  <a class="medical medical_review" href="/d/html/14942.html" rel="external">"Intraoperative fluid management", section on 'Dynamic parameters to assess volume responsiveness'</a> and  <a class="medical medical_review" href="/d/html/14942.html" rel="external">"Intraoperative fluid management", section on 'Goal-directed fluid therapy'</a>.)</p><p>Transesophageal echocardiography (TEE) is used in select patients to assess left ventricular cavity size to provide valuable information regarding ventricular filling (ie, hypovolemia or fluid overload)  (<a class="graphic graphic_movie graphicRef104149" href="/d/graphic/104149.html" rel="external">movie 1</a> and <a class="graphic graphic_diagnosticimage graphicRef109236" href="/d/graphic/109236.html" rel="external">image 1</a> and <a class="graphic graphic_diagnosticimage graphicRef104503" href="/d/graphic/104503.html" rel="external">image 2</a> and <a class="graphic graphic_table graphicRef106967" href="/d/graphic/106967.html" rel="external">table 3</a>), and both left and right ventricular function [<a href="#rid35">35</a>]. However, no randomized controlled trials exist to assess the utility of echocardiography to determine endpoints of resuscitation in the management of burn injured patients. (See  <a class="medical medical_review" href="/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Volume status'</a> and  <a class="medical medical_review" href="/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Ventricular function'</a>.)</p><p>Emergency use of intraoperative or perioperative TEE is indicated to determine the cause of any unexplained persistent or life-threatening hemodynamic instability ("rescue echo") when equipment and expertise are available [<a href="#rid36">36</a>]. (See  <a class="medical medical_review" href="/d/html/94296.html" rel="external">"Intraoperative rescue transesophageal echocardiography (TEE)"</a>.)</p><p class="headingAnchor" id="H3296011069"><span class="h2">Laboratory values</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Arterial blood gases (ABGs)</strong> <strong>and lactate</strong> – We intermittently monitor ABGs (eg, every hour during a major excision). We include lactate measurements as elevated lactate levels are an important indicator of reduced global tissue perfusion. Other centers use base deficit measurements as an alternative to lactate levels. Although increasing serum lactate levels (or lactic acidosis with a large base deficit) on sequential ABGs indicates persistent poor perfusion, these laboratory values do not provide information regarding contemporaneous clinical intravascular volume status since they are measured intermittently and do not immediately reflect acute changes. (See  <a class="medical medical_review" href="/d/html/2298.html" rel="external">"Etiology, clinical manifestations, and diagnosis of volume depletion in adults", section on 'Clinical manifestations'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Blood glucose</strong> – We monitor blood glucose levels throughout the perioperative period as peripheral insulin resistance, elevated protein, lipid catabolism, and stimulated synthesis of acute phase proteins induce a hyperglycemic response in burn injured patients. Hyperglycemia has been associated with increased likelihood of infections and sepsis in thermally injured and other critically ill patients. As a result, we monitor blood glucose levels every one to two hours and start an insulin infusion if the blood glucose level exceeds 180 mg/dL, with a goal of 100 to 180 mg/dL [<a href="#rid37">37-39</a>].</p><p></p><p class="headingAnchor" id="H1357316770"><span class="h1">AIRWAY MANAGEMENT</span><span class="headingEndMark"> — </span>General principles of difficult airway management apply to patients with burn injuries and are discussed separately  (<a class="graphic graphic_figure graphicRef135096" href="/d/graphic/135096.html" rel="external">figure 4</a> and <a class="graphic graphic_algorithm graphicRef134460" href="/d/graphic/134460.html" rel="external">algorithm 1</a>) (see  <a class="medical medical_review" href="/d/html/90615.html" rel="external">"Management of the difficult airway for general anesthesia in adults"</a>). Additionally, there are other factors to take into consideration when preparing to manage the airway of patients with burn injuries:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Difficulty with mask ventilation </strong>– Bag-mask ventilation of patients with burns to the face or neck may be challenging due to burn dressings that prevent a good seal around the mask. We employ two-person bag-mask ventilation technique for these patients and are quick to supplement with the placement of oropharyngeal airway (OPA). Removal of the burn dressing may be necessary, but extreme care is taken to prevent further damage to the burned area.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Difficulty with supraglottic airway (SGA) insertion </strong>–<strong> </strong>In some cases, an SGA may be inserted, but distortion of upper airway anatomy due to edema may cause difficulties with insertion and proper positioning of a supraglottic airway. In such cases, a flexible intubating scope (FIS) in addition to an airway exchange catheter can be used to exchange the SGA to a standard endotracheal tube.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Flexible intubating scope (FIS) </strong>– When upper airway anatomy is obscured or upper airway patency is a concern, we employ a FIS during intubation to identify specific abnormalities and to maximize chances for successful intubation  (<a class="graphic graphic_algorithm graphicRef134460" href="/d/graphic/134460.html" rel="external">algorithm 1</a>) [<a href="#rid40">40,41</a>]. If the patient is cooperative, we use awake FIS-guided tracheal intubation. If the patient cannot cooperate, we attempt to preserve spontaneous ventilation (with or without bag-mask assistance) to ensure adequate gas exchange during induction of anesthesia and laryngoscopy attempts. Preserving spontaneous ventilation may also facilitate advancement of the FIS into the trachea if laryngeal edema is distorting the fiberoptic view of the glottis. Viewing bubbling secretions and movement during opening of edematous tissue during spontaneous ventilation provides the clinician with a target to advance the scope into the airway. (See  <a class="medical medical_review" href="/d/html/89917.html" rel="external">"Flexible scope intubation for anesthesia", section on 'Preparation for awake intubation'</a>.)</p><p></p><p class="bulletIndent1">After induction of anesthesia, while maintaining spontaneous ventilation and before administering any neuromuscular blocking agent (NMBA), we test the ability to supplement ventilation with positive pressure by mask, and assess the upper airway anatomy either with a video assisted laryngoscope or flexible bronchoscope. If we can view recognizable glottic structures, a NMBA is administered to facilitate tracheal intubation. (See <a class="local">'Induction'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Difficulty securing the endotracheal tube (ETT) </strong>– Securing the ETT for patients with burns to the face is challenging. Techniques to achieve adequate fixation of the ETT include placement of cloth ties around the ETT that can then be secured around the neck, a technique that similarly works for patients with thick beards. Other methods include placement of interdental/maxillary wires [<a href="#rid42">42</a>], or surgical sutures around the teeth to secure the ETT at a desired depth [<a href="#rid43">43</a>]. Circum-mandibular, nasomaxillary, or transseptal sutures can also be used to secure the ETT in patients with facial burns, achieving reliable ETT fixation with minimal obstruction of the surgical field [<a href="#rid44">44</a>]. Additionally for edentulous patients or those with small teeth, intermaxillary fixation (IMF) screws can be used as anchor point for securing the endotracheal tube [<a href="#rid45">45,46</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Difficulty with performing a surgical airway </strong>–<strong> </strong>Performing a tracheostomy can be more challenging in a severely burned patient. There may be significant difficulties in patients with neck edema, contractures, or significant scarring, resulting in distortion of standard anatomic landmarks. The decision, including timing, is made on an individualized basis. (See  <a class="medical medical_review" href="/d/html/87444.html" rel="external">"Overview of complications of severe burn injury", section on 'Pulmonary failure'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk for rapid desaturation and hypoxemia </strong>–<strong> </strong>Patients with acute burn injuries are at risk for rapid desaturation and hypoxemia as a sequelae of their hypermetabolic state and increased oxygen consumption (VO<sub>2</sub>) (see  <a class="medical medical_review" href="/d/html/1623.html" rel="external">"Oxygen delivery and consumption", section on 'Increased metabolic demand'</a>), ventilation-perfusion mismatches, and or decreased functional lung capacities as discussed above. As a result, clinicians should maximize efforts to adequately preoxygenate patients prior to the induction of anesthesia.</p><p></p><p class="headingAnchor" id="H2837560914"><span class="h1">ANESTHETIC MANAGEMENT</span></p><p class="headingAnchor" id="H2622326119"><span class="h2">Altered pharmacokinetics and pharmacodynamics</span><span class="headingEndMark"> — </span>Doses of anesthetic agents required to induce and maintain appropriate anesthetic depth depend on the pathophysiologic state of the patient. Notably, altered pharmacokinetics and pharmacodynamics affect commonly used anesthetics, analgesics, and muscle relaxants [<a href="#rid4">4,47-49</a>]. The causes of these alterations include changes in plasma protein concentrations, changes in specific drug receptors, and other cardiovascular factors. In particular, reduced plasma albumin levels increase the volume of distribution and the available free fraction of any medication that binds to albumin (eg, benzodiazepines). Albumin levels are decreased because of plasma protein loss through endovascular "leaking," as well as protein dilution resulting from crystalloid resuscitation (see <a class="local">'Assess intravascular volume status'</a> above). Severely burned patients with burn shock have decreased cerebral, hepatic, and renal blood flow, which further affects pharmacokinetics and pharmacodynamics [<a href="#rid50">50</a>].</p><p class="headingAnchor" id="H2806339137"><span class="h2">Induction</span><span class="headingEndMark"> — </span>We administer a reduced dose of an intravenous (IV) anesthetic induction agent (eg, <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a>, <a class="drug drug_general" data-topicid="8428" href="/d/drug information/8428.html" rel="external">etomidate</a>, <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a>), usually combined with a small dose of opioid, to induce anesthesia during the acute resuscitative (ebb) phase immediately after a burn injury. Similar to induction for other patients undergoing trauma surgery who may have intravascular volume depletion, ketamine or etomidate is typically preferred. Furthermore, all anesthetic induction agents should be administered cautiously (ie, slow administration in reduced doses) as intravascular volume depletion and other factors such as burn severity, or concurrent sepsis may contribute to development of hypotension during the resuscitative phase [<a href="#rid4">4,51,52</a>]. (See  <a class="medical medical_review" href="/d/html/94581.html" rel="external">"Anesthesia for adult trauma patients", section on 'Induction'</a>.)</p><p>In contrast to the resuscitative (ebb) phase, higher doses of anesthetic agents may be necessary during the recovery (flow) phase. (See <a class="local">'Assess cardiovascular status'</a> above.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ketamine</strong><strong> </strong>– Induction with <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a> usually increases mean arterial pressure, heart rate, and plasma <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a> levels due to centrally-mediated sympathetic nervous system stimulation [<a href="#rid53">53</a>]. However, this stimulatory effect depends upon the presence of adequate sympathetic reserve. In patients who have maximally activated their sympathetic response (eg, burn patients with hypovolemic shock), administration may result in hypotension due to the direct myocardial depressant effects of ketamine [<a href="#rid4">4</a>]. Advantageous effects of ketamine include analgesic and bronchodilatory properties. Furthermore, if intubation proves to be difficult, a theoretical advantage of ketamine is maintenance of airway reflexes, respiratory drive, and spontaneous respiration. Potential adverse effects include nausea and vomiting, increased salivation that may obscure the view of a FIS, hallucinations, and emergence delirium. (See  <a class="medical medical_review" href="/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents", section on 'Ketamine'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etomidate</strong> – Induction with <a class="drug drug_general" data-topicid="8428" href="/d/drug information/8428.html" rel="external">etomidate</a> results in few hemodynamic changes in patients with cardiovascular compromise as compared with <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a>; thus, the dose is not typically decreased [<a href="#rid51">51-54</a>]. However, as noted above with <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a>, in patients who have maximally activated their sympathetic response (eg, burn patients with hypovolemic shock), administration of etomidate may also result in hypotension due to a mild direct myocardial depressant effect. A disadvantage is the association of etomidate with transient acute adrenal insufficiency [<a href="#rid55">55-58</a>], and possibly increased risk of mortality in both critically ill [<a href="#rid57">57</a>] and noncritically ill patients [<a href="#rid59">59</a>]. However, this finding is not consistent [<a href="#rid60">60</a>], and there are no studies examining safety of etomidate compared with other induction agents in burn patients. (See  <a class="medical medical_review" href="/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents", section on 'Etomidate'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Propofol</strong><strong> </strong>– The induction dose of <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> is reduced during the acute resuscitative (ebb) phase, similar to other traumatically injured patients, to avoid further cardiovascular depression and reduction in systemic vascular resistance [<a href="#rid51">51,53,61</a>]. (See  <a class="medical medical_review" href="/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents", section on 'Propofol'</a>.)</p><p></p><p class="bulletIndent1">However, during the hyperdynamic recovery (flow) phase three to four days later and thereafter, larger bolus doses or increased infusion rates of <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> may be necessary to attain and maintain therapeutic plasma propofol concentrations in patients with burn injuries (compared with those who are not burned) [<a href="#rid62">62,63</a>]. Hepatic clearance continues to account for the majority of total propofol clearance during this hyperdynamic flow state despite a burn-induced hepatic ischemic-reperfusion injury [<a href="#rid62">62</a>]. Both hepatic and renal clearance increase because reduction in albumin plasma levels increases the free propofol fraction. These pharmacokinetic changes result in plasma propofol concentrations that are lower for a given dosing regimen, accounting for increased dosing requirements during the flow phase [<a href="#rid63">63</a>]. Although higher doses of propofol may be necessary during the recovery phase, caution is still necessary during administration of induction doses because interaction with other prescribed medications (eg, opioids, beta blockers) may produce hypotension.</p><p></p><p class="headingAnchor" id="H262189525"><span class="h2">Use of succinylcholine</span><span class="headingEndMark"> — </span>During the first 48 hours following a major burn (see <a class="local">'Note estimated burn extent and severity'</a> above), <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a> (SCh) may be used, but must be avoided for at least one year after that first 48 hours due to risk of acute severe hyperkalemia and life-threatening arrhythmias [<a href="#rid4">4,64</a>]. Since serum potassium may be initially elevated after a major burn due to cellular injury, any further increase may trigger cardiac arrhythmias. Risk of hyperkalemia is further increased in burn patients with infection, sepsis, or immobilization [<a href="#rid64">64</a>].</p><p>Severe hyperkalemia after SCh administration occurs as a result of upregulation of immature extra junctional nicotinic acetylcholine receptor (nAChR) subunits caused by inflammation and local denervation of muscle [<a href="#rid64">64,65</a>]. Upregulation of nAChR receptors has been demonstrated to occur as soon as 24 hours after injury in the alpha-7 and gamma gene subunit, although there are no reports of hyperkalemia before 72 hours after a burn in humans [<a href="#rid65">65</a>]. In animal models, upregulation of nAChR occurs approximately 72 hours after the injury even with burns of 5 percent of total body surface area (TBSA) [<a href="#rid66">66</a>]. Thus, a conservative approach is to avoid administration of SCh after 48 hours following a burn injury.</p><p class="headingAnchor" id="H704215283"><span class="h2">Use of nondepolarizing neuromuscular blockading agents</span><span class="headingEndMark"> — </span>Close monitoring of the degree of neuromuscular blockade is critically important after administration of NMBAs. Approximately one week after burns involving &gt;30 percent of TBSA, resistance to all nondepolarizing NMBAs develops that is proportional to burn size, with peak resistance occurring five to six weeks after injury [<a href="#rid67">67</a>]. Also, recovery time from neuromuscular blockade is shortened. Thus, it is often necessary to increase doses and frequency of NMBA administration to partially overcome this increased resistance and more rapid recovery [<a href="#rid49">49,68-71</a>]. Rapid sequence induction (RSI) dosing of <a class="drug drug_general" data-topicid="9872" href="/d/drug information/9872.html" rel="external">rocuronium</a> should therefore be increased to 1.5mg/kg [<a href="#rid4">4</a>].</p><p>Resistance to all nondepolarizing NMBAs occurs, in part, due to upregulation of nAChR subunits, as described above [<a href="#rid64">64,65</a>]. An additional factor is an increase in acute phase alpha 1-glycoprotein levels, which increases plasma protein binding of NMBAs [<a href="#rid68">68</a>]. Additionally, enhanced renal elimination of NMBA may occur in the later hyperdynamic (flow) stage of the burn injury because of normalization of acute glycoprotein levels and increased glomerular filtration [<a href="#rid49">49,69</a>].</p><p>In the case of the nondepolarizing NMBAs <a class="drug drug_general" data-topicid="8973" href="/d/drug information/8973.html" rel="external">atracurium</a> and <a class="drug drug_general" data-topicid="9270" href="/d/drug information/9270.html" rel="external">cisatracurium</a>, which are metabolized in the plasma through organ-independent Hofmann elimination, resistance occurs primarily due to upregulation of nAChRs rather than altered protein binding [<a href="#rid70">70</a>]. (See  <a class="medical medical_review" href="/d/html/94535.html" rel="external">"Clinical use of neuromuscular blocking agents in anesthesia", section on 'Cisatracurium'</a> and  <a class="medical medical_review" href="/d/html/94535.html" rel="external">"Clinical use of neuromuscular blocking agents in anesthesia", section on 'Atracurium'</a>.)</p><p>Despite ACh receptor upregulation and these pharmacokinetic effects on NMBA activity, we do not modify dosing or timing of anticholinesterase agents (eg, <a class="drug drug_general" data-topicid="9693" href="/d/drug information/9693.html" rel="external">neostigmine</a>) or <a class="drug drug_general" data-topicid="105866" href="/d/drug information/105866.html" rel="external">sugammadex</a> administered to reverse neuromuscular blockade. (See  <a class="medical medical_review" href="/d/html/94535.html" rel="external">"Clinical use of neuromuscular blocking agents in anesthesia", section on 'Reversal of neuromuscular block'</a>.)</p><p class="headingAnchor" id="H887457156"><span class="h2">Choice of maintenance technique</span><span class="headingEndMark"> — </span>To maintain anesthesia for burn surgery, we typically select an inhalation-based or a "balanced," technique employing an inhalation anesthetic, an opioid such as <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a> or <a class="drug drug_general" data-topicid="8538" href="/d/drug information/8538.html" rel="external">hydromorphone</a>, and a neuromuscular blocking agent (NMBA) due to generally lower costs compared with use of total IV anesthesia (TIVA) techniques. We titrate inhalation agents cautiously while monitoring the patient's hemodynamic responses. We typically administer small doses of a benzodiazepine and/or <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a> as adjuvants to decrease risk of intraoperative awareness, and administer NMBAs as needed. (See  <a class="medical medical_review" href="/d/html/96308.html" rel="external">"Maintenance of general anesthesia: Overview"</a>.)</p><p>We reserve use of TIVA for patients who require special ventilator parameters (eg, high-frequency ventilation) that are not available on most anesthetic workstations. When we do select a TIVA technique, we prefer continuous infusions of <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a>, <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a>, and an opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a> or <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">remifentanil</a>), in combination with an NMBA. A retrospective study in burn patients undergoing debridement and grafting compared an inhalation-based anesthesia technique to a ketamine-based TIVA technique that included propofol and an opioid; overall outcomes and use of vasopressors were similar [<a href="#rid72">72</a>].</p><p class="headingAnchor" id="H633600264"><span class="h2">Use of intraoperative opioids</span><span class="headingEndMark"> — </span>Opioids such as <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a> or <a class="drug drug_general" data-topicid="8538" href="/d/drug information/8538.html" rel="external">hydromorphone</a> are an essential component of a balanced anesthetic technique, particularly since significant postoperative pain is anticipated.</p><p>Opioid doses are reduced during the acute resuscitative (ebb) phase because metabolic clearance may be impaired by liver dysfunction [<a href="#rid73">73</a>]. In the subsequent recovery (flow) phase, opioid requirements may increase due to their substantially expanded volumes of distribution (ie, dilutional expansion) [<a href="#rid4">4,48</a>]. Furthermore, the degree of preoperative opioid use affects intraoperative opioid dosing, particularly for patients with large burns who have required prolonged opioid therapy and/or long-acting opioids. Near the end of the surgical procedure, opioids may be titrated to achieve an adequate spontaneous respiratory rate to individualize dosing.</p><p class="headingAnchor" id="H103618570"><span class="h2">Use of local and regional anesthesia</span><span class="headingEndMark"> — </span>Local and regional anesthetic techniques provide supplemental intraoperative anesthesia, improve postoperative analgesia, and decrease opioid requirements [<a href="#rid4">4</a>]. (See <a class="local">'Challenges in pain management'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Local anesthesia </strong>– The volume of local anesthetics that can be infiltrated without reaching toxic doses is limited. Subcutaneous tumescent infiltration of local anesthetics for cutaneous surgery may provide adequate surgical anesthesia, with less blood loss from the graft donor sites [<a href="#rid74">74-76</a>]. Donor sites are typically more painful than the grafted burn wound itself because they are effectively fresh injuries, and deep-partial or full thickness injuries are associated with nerve damage and are often sensate to pressure only [<a href="#rid77">77</a>]. In one feasibility study (n = 8 patients), postoperative pain was decreased by continuous infusion of subcutaneous <a class="drug drug_general" data-topicid="9169" href="/d/drug information/9169.html" rel="external">bupivacaine</a> into the donor sites [<a href="#rid78">78</a>]. <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">Lidocaine</a> infusions may also be useful in reducing perioperative opiate consumption as well [<a href="#rid79">79</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Regional anesthesia </strong>– Regional anesthetic techniques are particularly useful for intraoperative excision of small and/or localized burns [<a href="#rid80">80</a>]. However, efficacy of regional techniques as the sole anesthetic for surgical procedures in burn patients is usually limited due to the location and size of burn injuries, use of multiple distant donor sites for skin harvesting, and other associated painful traumatic injuries. In our institution we emphasize regional techniques to reduce perioperative opiate consumption, with priority being focused on targeting the split-thickness donor site [<a href="#rid80">80</a>]. This is typically accomplished by the use of ultrasound guided suprainguinal fascia iliaca plane blocks, reliably covering both lateral femoral cutaneous and femoral nerve dermatomes, and therefore the anterolateral thigh.</p><p></p><p class="headingAnchor" id="H463535031"><span class="h1">FLUID AND TRANSFUSION MANAGEMENT</span><span class="headingEndMark"> — </span>Intravascular volume and hemodynamics are maintained to optimize end-organ perfusion and prevent burn shock [<a href="#rid4">4</a>]. The American Burn Association (ABA) recommends maintaining urine output ≥0.5 mL/kg per hour for adults and ≥1 mL/kg per hour for children ≤30 kg, although the best endpoints for adequacy of resuscitation after major burn injury are not conclusively determined. (See  <a class="medical medical_review" href="/d/html/16320.html" rel="external">"Overview of the management of the severely burned patient", section on 'Intensive care management'</a> and  <a class="medical medical_review" href="/d/html/6567.html" rel="external">"Moderate and severe thermal burns in children: Emergency management", section on 'Monitoring fluid status'</a>.)</p><p class="headingAnchor" id="H2781902746"><span class="h2">Fluid administration</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Selection of fluid</strong> – As recommended by the ABA, we typically administer crystalloid solutions (Lactate Ringers) rather than colloid solutions during the initial phase of burn resuscitation at a rate of 2 mL x patient's body weight in kg x % second and third degree burns, with half of the 24-hour total (in mLs) infused over the first eight hours [<a href="#rid12">12,81,82</a>]. However, some institutions administer hypertonic or colloid solutions (eg, albumin, fresh frozen plasma [FFP]), particularly if patients have inadequate urine output or evidence of poor perfusion (eg, elevated lactate values) [<a href="#rid13">13,83</a>] (see <a class="local">'Laboratory values'</a> above). Although vasoactive agents such as <a class="drug drug_general" data-topicid="9709" href="/d/drug information/9709.html" rel="external">norepinephrine</a> are administered in some centers to reduce initial volume administration and improve cardiac output in the early phases of resuscitation [<a href="#rid13">13</a>], efforts should be made to minimize the use of vasoconstrictors perioperatively as they theoretically may induce ischemia at the burn graft site that may negatively impact graft success. (See  <a class="medical medical_review" href="/d/html/350.html" rel="external">"Emergency care of moderate and severe thermal burns in adults", section on 'Fluid resuscitation'</a> and  <a class="medical medical_review" href="/d/html/14942.html" rel="external">"Intraoperative fluid management", section on 'Choosing fluid: Crystalloid, colloid, or blood'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Volume of fluid</strong> – In general, during early excisions such as debridement or escharotomies, intraoperative volume losses are added in addition to formula-guided resuscitative fluid volume (eg, ABA formula). (See  <a class="medical medical_review" href="/d/html/350.html" rel="external">"Emergency care of moderate and severe thermal burns in adults", section on 'Estimating initial fluid requirements'</a>.)</p><p></p><p class="bulletIndent1">During later stages of the burn injury, intraoperative fluid administration, as well as transfusion decisions (see <a class="local">'Transfusion decisions'</a> below), are adjusted according to the magnitude of burn excisions, volume of blood loss (large excisions incur more blood loss and require more volume replacement), burn depth (partial-thickness excisions involve more blood loss than full-thickness excisions), specific hemostatic techniques used (eg, topical vasoconstrictors), and surgical administration of tumescent fluid. (See  <a class="medical medical_review" href="/d/html/350.html" rel="external">"Emergency care of moderate and severe thermal burns in adults", section on 'Fluid resuscitation'</a>.)</p><p></p><p class="bulletIndent1">Optimal fluid replacement avoids under- or over-resuscitation, both of which may lead to further complications in the postoperative period (see <a class="local">'Assess intravascular volume status'</a> above). Guiding factors include estimated severity of ongoing blood loss, hemoglobin measurements, development of hypoxemia, adequacy of urine output with a target of &gt;0.5 mL/kg per hour, and other clinical assessments of perfusion. Laboratory values (eg, base deficit and serum lactate) provide additional information regarding adequacy of intravascular fluid volume, although this information is not contemporaneous and does not immediately reflect acute changes. (See <a class="local">'Dynamic hemodynamic parameters'</a> above and <a class="local">'Laboratory values'</a> above.)</p><p></p><p class="headingAnchor" id="H1634675328"><span class="h2">Transfusion decisions</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Restrictive transfusion strategy</strong> – We employ a restrictive transfusion strategy in hemodynamically stable patients without massive blood loss, with transfusion of a unit of packed red blood cells (RBCs) at a hemoglobin transfusion threshold of &lt;7 to 8 g/dL (hematocrit &lt;21 to 24 percent), similar to other surgical procedures [<a href="#rid84">84-88</a>] (see  <a class="medical medical_review" href="/d/html/112610.html" rel="external">"Intraoperative transfusion and administration of clotting factors", section on 'Red blood cells'</a>). However, decisions to transfuse are individualized. We typically use a higher hemoglobin threshold of &lt;9 g/dL (approximately equivalent to a hematocrit ≤27 percent) in patients who have significant ongoing or anticipated bleeding (eg, due to extensive excisions), known acute coronary syndrome, or signs of myocardial or other organ ischemia. Intraoperative blood losses during burn debridement or escharotomies can be large. It is estimated that 2.6 percent of an adult patient's total blood volume is lost (or 3.4 percent in children) for each 1 percent of burn wound excised or autograft harvested [<a href="#rid89">89,90</a>]. (See  <a class="medical medical_review" href="/d/html/350.html" rel="external">"Emergency care of moderate and severe thermal burns in adults", section on 'Blood transfusion'</a>.)</p><p></p><p class="bulletIndent1">In one randomized multicenter trial in 345 patients with ≥20 percent TBSA burns, a restrictive hemoglobin transfusion strategy with the threshold set at 7 to 8 g/dL resulted in fewer transfused units of RBCs compared with a liberal strategy with the threshold set at 10 to 11 g/dL [<a href="#rid85">85</a>]. Mean transfused units/patient were 20.3 ± 32.7 in the restrictive transfusion group versus 31.8 ± 44.3 in the liberal transfusion group (p &lt;0.001). Secondary outcomes that included bloodstream infection, organ dysfunction, and mortality did not differ between the restrictive and liberal transfusion groups [<a href="#rid85">85</a>]. Potential benefits of a restrictive RBC transfusion threshold in other surgical and critically ill patient populations (eg, reduced risk for infectious complications and mortality) are discussed separately. (See  <a class="medical medical_review" href="/d/html/112610.html" rel="external">"Intraoperative transfusion and administration of clotting factors", section on 'Red blood cells'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other techniques to minimize transfusion</strong> – Several techniques are used to minimize intraoperative bleeding and need for transfusion during surgical procedures in burned patients, including application of <a class="drug drug_general" data-topicid="10285" href="/d/drug information/10285.html" rel="external">topical thrombin</a>, use of compressive devices (tourniquets), topical or subcutaneous injection of vasoconstrictors (eg, <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a>, vasopressin analogs, <a class="drug drug_general" data-topicid="9768" href="/d/drug information/9768.html" rel="external">phenylephrine</a>), and use of staged procedures [<a href="#rid91">91</a>]. A combination of these techniques may be used to decrease blood loss and transfusion requirements [<a href="#rid92">92</a>]. Despite these efforts, burn excisions are often accompanied by significant blood loss.</p><p></p><p class="bulletIndent1">Topical <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a> is the most commonly used technique to limit blood loss in both burn excision and donor skin harvest sites. The anesthesiologist should monitor for potential systemic effects of absorbed epinephrine (eg, increased blood pressure, heart rate, or serum glucose) after topical application or subcutaneous injection [<a href="#rid93">93,94</a>]. Compared with other patients needing skin grafts, topical epinephrine use during skin grafting in burn patients resulted in increased serum epinephrine and lactate levels, a higher lactate-pyruvate ratio, and higher heart rates in one study [<a href="#rid93">93</a>]. However, other studies reported no difference in catecholamine levels or hemodynamic parameters when epinephrine solutions were used in burn patients versus patients undergoing other surgical procedures [<a href="#rid95">95,96</a>]. Subcutaneous infiltration of skin donor sites with <a class="drug drug_general" data-topicid="9768" href="/d/drug information/9768.html" rel="external">phenylephrine</a> 5 mcg/mL effectively reduces blood loss without systemic effects [<a href="#rid97">97</a>]. However, use of topical or subcutaneous vasoconstrictors, including phenylephrine or epinephrine, can mask hypovolemia during excision of large areas of burned tissue.</p><p></p><p class="bulletIndent1">Administration of <a class="drug drug_general" data-topicid="10011" href="/d/drug information/10011.html" rel="external">tranexamic acid</a> (TXA), a lysine analog that inhibits fibrinolysis, may improve hemostasis in burn surgery as in other types of trauma surgery. However, risk of thromboembolism is a concern, particularly in burn patients [<a href="#rid98">98,99</a>]. Small studies of TXA administered as a single dose before surgical incision for surgical procedures in burn patients noted reduced blood loss, while side effects such as thromboembolism were not noted [<a href="#rid100">100,101</a>]. These findings are further supported by a recent meta-analysis of eight trials that demonstrated that intraoperative TXA administration was associated with decreased EBL as well as packed RBC transfusions, but did not impact overall length of stay, thromboembolic events, or mortality [<a href="#rid102">102</a>]. Further details regarding use of antifibrinolytic agents in trauma patients are discussed in other topics:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/15147.html" rel="external">"Etiology and diagnosis of coagulopathy in trauma patients"</a> and  <a class="medical medical_review" href="/d/html/117817.html" rel="external">"Ongoing assessment, monitoring, and resuscitation of the severely injured patient", section on 'Management of acute traumatic coagulopathy'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/113837.html" rel="external">"Initial management of moderate to severe hemorrhage in the adult trauma patient", section on 'Antifibrinolytic agents'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/117817.html" rel="external">"Ongoing assessment, monitoring, and resuscitation of the severely injured patient", section on 'Tranexamic acid'</a>.)</p><p></p><p class="bulletIndent1">We do not administer activated recombinant factor VII (rFVIIa) to reduce transfusion due to increased risk of thromboembolic complications in burn patients [<a href="#rid98">98,99</a>]. Although the use of rFVIIa was associated with a 60 percent reduction in the number of blood products transfused in one small study of 18 patients with burn injuries [<a href="#rid103">103</a>], increased risk of thrombosis has been noted in various settings [<a href="#rid104">104</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Massive blood transfusion and coagulopathy</strong> – Severely burned patients may experience an intraoperative trauma-induced coagulopathy due to fluid shifts, hemodilution, and hypothermia, particularly if there are other concurrent traumatic injuries [<a href="#rid105">105,106</a>]. (See <a class="local">'Fluid administration'</a> above.)</p><p></p><p class="bulletIndent1">Occasional patients experience massive intraoperative blood loss (ie, &gt;50 percent of blood volume) during excision and grafting procedures for large or severe burns. When this occurs, we limit crystalloid administration (see <a class="local">'Fluid administration'</a> above), and we employ a resuscitation protocol using a 1:1 ratio of RBCs to packed FFP with administration of platelets and cryoprecipitate as necessary. This approach is similar to protocols for massive transfusion in other settings [<a href="#rid107">107</a>]. (See  <a class="medical medical_review" href="/d/html/7931.html" rel="external">"Massive blood transfusion", section on 'Approach to volume and blood replacement'</a>.)</p><p></p><p class="headingAnchor" id="H3699412573"><span class="h2">Hemodynamic management</span><span class="headingEndMark"> — </span>The most important strategy for maintenance of hemodynamic stability is tailored crystalloid fluid administration, as noted above (see <a class="local">'Fluid administration'</a> above). Burn shock is the result of the interaction of increased microvascular permeability leading to hypovolemia, massive release of catecholamines that cause increased systemic vascular resistance, and some degree of myocardial dysfunction that overlap during the progression of the burn injury and treatment [<a href="#rid108">108</a>]. Characteristics that complicate burn resuscitation and anesthetic management include existing cardiac disease, renal failure, inhalation injury, obesity, anuria, mechanical ventilation and extremes of age (see <a class="local">'Preanesthetic assessment'</a> above). Advanced cardiac function monitoring as well as use of vasoactive and/or inotropic agents might be beneficial if profound hypotension or signs of tissue hypoperfusion develop. However, the systemic effects of vasoactive agents may have local adverse effects on the injured skin and on skin grafts. Overall, evidence is scant regarding benefits and harms of using vasoactive and/or inotropic drugs in addition to fluids during early resuscitation of major burn patients [<a href="#rid109">109</a>]. In our institution, when patients demonstrate ongoing hypotension despite their predicted crystalloid volume resuscitation (see  <a class="medical medical_review" href="/d/html/350.html" rel="external">"Emergency care of moderate and severe thermal burns in adults", section on 'Fluid resuscitation'</a>), we then initiate <a class="drug drug_general" data-topicid="9709" href="/d/drug information/9709.html" rel="external">norepinephrine</a> infusions titrated to achieve a mean arterial pressure of &gt;65 mmHg with vasopressin being added as a second line agent. In a recent single center randomized controlled trial, the use of vasopressin versus placebo in 100 hemorrhagic shock patients, demonstrated that the use of vasopressin was associated with decreased blood product requirements [<a href="#rid110">110</a>]. While acute burn pathophysiology is distinct and complex, intraoperative management can mimic trauma resuscitations as hemodilution from large volume crystalloid resuscitations can result in a dilutional coagulopathy that is further compounded by major blood loss associated with large TBSA excisions. We routinely initiate vasopressin infusions at a fixed rate of 0.03 to 0.04 units/minute.</p><p class="headingAnchor" id="H3007389599"><span class="h1">TEMPERATURE MANAGEMENT</span><span class="headingEndMark"> — </span>We prevent intraoperative hypothermia by using convective warming devices (ie, forced air warmers), administering warmed intravenous fluids, maintaining a warm ambient room temperature ≥25°C, and minimizing exposed body surface area. As explained in a separate topic, hypothermia is associated with increased risk of coagulopathy, infection including sepsis, and mortality. (See  <a class="medical medical_review" href="/d/html/94588.html" rel="external">"Perioperative temperature management"</a>.)</p><p>In addition to redistribution as a source of body temperature reduction, burn patients have a particularly high risk for perioperative hypothermia because of accelerated evaporative, convective, and radiative heat loss through injured skin, exacerbated by prolonged exposure of a large surface area to ambient temperature during the length of the surgical procedure [<a href="#rid4">4,111</a>]. Exposure time includes skin preparation and the surgical procedures including excision at donor and graft sites. Even if there are no burned skin areas, cold room temperatures can significantly lower core temperature, particularly during the first hour after induction of anesthesia. Hypothermia is also exacerbated by administration of cold intravenous (IV) fluids. For all of these reasons, patients with major burns can lose up to 1°C every 15 minutes if exposed to ambient temperature.</p><p class="headingAnchor" id="H463535052"><span class="h1">POSTOPERATIVE MANAGEMENT</span></p><p class="headingAnchor" id="H2774886841"><span class="h2">Use of mechanical ventilation</span><span class="headingEndMark"> — </span>Postoperative mechanical ventilation is typically necessary for patients with:</p><p class="bulletIndent1"><span class="glyph">●</span>Inhalation burn injury, particularly if acute respiratory distress syndrome (ARDS) develops. The role of extracorporeal membrane oxygenation (ECMO) for severe respiratory failure in patients with burns and smoke inhalation is unclear and requires further study [<a href="#rid112">112,113</a>]. A recent meta-analysis of 15 retrospective studies including 318 patients demonstrated the pooled successful weaning from ECMO was 65 percent, with worse outcomes being associated with inhalational injuries and severe burns [<a href="#rid114">114</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with increased risk of ongoing bleeding, intraoperative hypothermia, or expected frequent returns to the operating room for additional surgery are generally not extubated [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Risk for graft disruption due to movement (eg, delicate sheet grafting to the face and neck). Postoperative mechanical ventilation in a deeply sedated patient minimizes this risk.</p><p></p><p class="headingAnchor" id="H17826985"><span class="h2">Challenges in pain management</span><span class="headingEndMark"> — </span>Continuous pain management and intermittent sedation for bedside procedures are treatment priorities in the postoperative period [<a href="#rid4">4</a>]. Opioid tolerance, characterized by increasingly poor analgesic response to standard doses of analgesics, is a factor that makes pain management challenging during all phases of burn care [<a href="#rid115">115</a>]. Thus, we use multimodal opioid-sparing techniques including nonopioid analgesics and local or regional anesthetic techniques whenever possible. These pharmacologic and nonpharmacologic pain management techniques have been reviewed by the American Burn Association (ABA) Committee on Delivery of Burn Care [<a href="#rid116">116</a>]. Key recommendations include the need for regular pain assessment using appropriate tools, individualizing opioid therapy, using non-opioid analgesics (eg, <a class="drug drug_general" data-topicid="9242" href="/d/drug information/9242.html" rel="external">acetaminophen</a>, <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a>) whenever possible, incorporating regional analgesia techniques, and emphasizing use of concomitant non-pharmacologic techniques. (See  <a class="medical medical_review" href="/d/html/14989.html" rel="external">"Management of burn wound pain and itching"</a> and  <a class="medical medical_review" href="/d/html/2888.html" rel="external">"Pain control in the critically ill adult patient", section on 'Multimodal analgesia'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pharmacologic agents </strong>– Specific pharmacologic agents used to manage postoperative pain in burn patients include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Opioids </strong>– Opioids remain a mainstay of therapy in burn patients. However, acute tolerance, a phenomenon whereby administration of opioids has a diminishing effect over a short period of time, may develop in burn patients after only two weeks of uninterrupted opioid use, particularly in patients with a preexisting opioid use disorder. Use of long-acting opioids may be helpful in some burn patients [<a href="#rid117">117,118</a>]. <a class="drug drug_general" data-topicid="9623" href="/d/drug information/9623.html" rel="external">Methadone</a> has an additional analgesic advantage due to N-methyl-D-aspartate (NMDA) receptor blockade (see  <a class="medical medical_review" href="/d/html/130113.html" rel="external">"Perioperative uses of intravenous opioids: Specific agents", section on 'Methadone'</a>). Notably, it is possible for burn-injured patients to develop opioid-induced hyperalgesia (OIH), a condition distinct from acute tolerance that is characterized by nociceptive sensitization, with greater sensitivity to painful stimuli. These phenomena may increase postoperative pain and opioid dose requirements. Details regarding use of opioids in patients with burn injuries and other critical illnesses are available in other topics:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/d/html/14989.html" rel="external">"Management of burn wound pain and itching", section on 'Opioid analgesics'</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/d/html/94536.html" rel="external">"Perioperative uses of intravenous opioids in adults: General considerations", section on 'Prevention and management of adverse opioid effects'</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/d/html/2888.html" rel="external">"Pain control in the critically ill adult patient", section on 'Opioid analgesics'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Ketamine</strong><strong> </strong>–<strong> </strong><a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">Ketamine</a> has potent analgesic efficacy mediated by NMDA receptor blockade, which can produce analgesic relief in patients with opioid tolerance and/or OIH [<a href="#rid115">115,119-121</a>]. For these reasons, ketamine is often administered to burn patients outside of the operating room during dressing changes, hydrotherapy, and other procedures [<a href="#rid116">116</a>]. It is important to highlight that ketamine when used for procedural sedation can be associated with dysphoric hallucinations, but can be mitigated by amnestic effects of short acting benzodiazepines such as <a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a> [<a href="#rid122">122</a>].</p><p></p><p class="bulletIndent2">Other beneficial effects of <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a> include bronchodilation, and maintenance of hemodynamic stability, airway reflexes, and spontaneous ventilation [<a href="#rid4">4,123,124</a>]. Also, ketamine-based total intravenous anesthesia (TIVA) has been used to manage critically-ill burn patients who require specialized perioperative mechanical ventilation precluding use of a conventional anesthesia machine and inhalation anesthetic agents [<a href="#rid72">72</a>]. (See  <a class="medical medical_review" href="/d/html/14989.html" rel="external">"Management of burn wound pain and itching", section on 'Nonopioid analgesics'</a> and  <a class="medical medical_review" href="/d/html/2888.html" rel="external">"Pain control in the critically ill adult patient", section on 'Ketamine'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Dexmedetomidine</strong><strong> </strong>– <a class="drug drug_general" data-topicid="8897" href="/d/drug information/8897.html" rel="external">Dexmedetomidine</a> provides sedation, anxiolysis, and analgesia, with less respiratory depression than other sedatives, and is often used as a pain management adjunct, particularly as a first-line sedative in the intubated burn patient [<a href="#rid116">116,125</a>]. (See  <a class="medical medical_review" href="/d/html/2888.html" rel="external">"Pain control in the critically ill adult patient", section on 'Dexmedetomidine'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Acetaminophen</strong><strong> </strong>– <a class="drug drug_general" data-topicid="9242" href="/d/drug information/9242.html" rel="external">Acetaminophen</a> is routinely used in many burn centers as part of a multimodal pain regimen. (See  <a class="medical medical_review" href="/d/html/2888.html" rel="external">"Pain control in the critically ill adult patient", section on 'Acetaminophen'</a>.)</p><p></p><p class="bulletIndent1">Although administration of other systemic analgesic agents (eg, gabapentinoids, <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a>) has been described, data demonstrating their efficacy are limited in patients with burn injuries; thus, use of these agents is uncommon. Gabapentinoids have largely been disproven to impact acute pain in other settings [<a href="#rid126">126</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonpharmacologic agents </strong>– Nonpharmacologic techniques are used to manage postoperative pain when feasible, including infiltration of local anesthetics and regional anesthetic techniques, which may reduce opioid requirements, improve pain relief and patient satisfaction, and promote rehabilitation [<a href="#rid4">4</a>]. (See <a class="local">'Use of local and regional anesthesia'</a> above.).</p><p></p><p class="headingAnchor" id="H4112450316"><span class="h2">Other issues</span><span class="headingEndMark"> — </span>Other critical therapeutic interventions, including nutritional support, temperature management, beta blocker administration, and deep venous thrombosis prophylaxis are initiated or continued in the early postoperative period. (See  <a class="medical medical_review" href="/d/html/87444.html" rel="external">"Overview of complications of severe burn injury"</a>.)</p><p class="headingAnchor" id="H3503984867"><span class="h1">LATER SCAR REVISION PROCEDURES</span><span class="headingEndMark"> — </span>Scar revision procedures may be performed weeks or years after the initial burn injury. Lung injury is generally resolved by the time of these later procedures. However, airway management may be difficult due to fibrous tissue deposition and scarring. For example, skin contractures of the neck and mouth can distort upper airway anatomy, causing severely constricted mouth opening and/or limited neck movement (particularly neck extension). Some patients develop tracheal stenosis as a consequence of prolonged or multiple tracheal intubations, and/or tracheostomy placement. Management of a potentially difficult airway management is described in detail in a practice guideline developed by the American Society of Anesthesiologists (ASA), and in a separate topic [<a href="#rid127">127</a>]. (See  <a class="medical medical_review" href="/d/html/90615.html" rel="external">"Management of the difficult airway for general anesthesia in adults"</a>.)</p><p>Notably, chest wall contractures can result from spontaneously healed or grafted circumferential truncal burns, creating a restriction due to decreased chest wall compliance. (See  <a class="medical medical_review" href="/d/html/94363.html" rel="external">"Anesthesia for patients with interstitial lung disease or other restrictive disorders"</a>.)</p><p>Other considerations include the need for a multimodal analgesic approach after painful procedures to treat burn scars, including vigilant pain assessment and compassionate attention to anxiety and other psychosocial contributors to pain [<a href="#rid30">30</a>]. Opioid tolerance (or even hyperalgesia) acquired during the initial management of a major burn create challenges for pain management during subsequent procedures. Strategies include early consultation with pain specialists and use of <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a> infusion and/or NMDA-modulating analgesic agents.</p><p class="headingAnchor" id="H4222677967"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/117752.html" rel="external">"Society guideline links: Care of the patient with burn injury"</a>.)</p><p class="headingAnchor" id="H1968243030"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preanesthetic assessment </strong>–<strong> </strong>This includes assessing for presence of inhalation injury and associated respiratory dysfunction, potential for difficult airway, current cardiovascular and intravascular volume status, understanding the proposed surgical procedure and anticipated blood loss, and whether nutritional supplementation (enteral, parenteral) should be continued throughout the perioperative period. (See <a class="local">'Preanesthetic assessment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring considerations </strong>– We typically monitor dynamic hemodynamic parameters to maintain optimal intravascular volume and hemodynamic stability (including administration of vasoactive agents). We routinely monitor serial arterial blood gases for further guidance on serum lactate levels and global tissue perfusion. (See <a class="local">'Intraoperative monitoring'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Airway management </strong>–<strong> </strong>General principles of difficult airway management are discussed separately  (<a class="graphic graphic_figure graphicRef135096" href="/d/graphic/135096.html" rel="external">figure 4</a> and <a class="graphic graphic_algorithm graphicRef134460" href="/d/graphic/134460.html" rel="external">algorithm 1</a>). (See <a class="local">'Airway management'</a> above and  <a class="medical medical_review" href="/d/html/90615.html" rel="external">"Management of the difficult airway for general anesthesia in adults"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Difficulty with mask ventilation </strong>– We anticipated challenging mask ventilation and routinely use a two-person bag mask ventilation with supplemental oropharyngeal airway.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Difficulty with supraglottic airway (SGA) insertion </strong>–<strong> </strong>In some cases, an SGA may be inserted, but distortion of upper airway anatomy due to edema may cause difficulties with insertion and proper positioning of a supraglottic airway.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Use of a flexible intubating scope (FIS) </strong>– When upper airway anatomy is obscured or upper airway patency is a concern, we employ a FIS during intubation to identify specific abnormalities and to maximize chances for successful intubation.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Difficulty with securing the endotracheal tube (ETT) </strong>– Techniques to achieve adequate fixation of the ETT include placement of cloth ties around the ETT that can be secured circumferentially around the patient’s neck, interdental wires, surgical sutures around the teeth, or circum-mandibular, nasomaxillary, or transseptal sutures.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Difficulty with performing a surgical airway </strong>–<strong> </strong>Performing a tracheostomy is challenging in a severely burned patient due to potential difficulties in patients with neck edema, contractures, or significant scarring. The decision, including timing, is made on an individualized basis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anesthetic management </strong>–<strong> </strong>Altered pharmacokinetics and pharmacodynamics affect anesthetics, analgesics, and muscle relaxants due to reduced plasma albumin levels (with increased volume of distribution and available free fraction of medications that bind to albumin), alterations in specific drug receptors, and cardiovascular factors. (See <a class="local">'Altered pharmacokinetics and pharmacodynamics'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Induction</strong> – We typically administer <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a> or <a class="drug drug_general" data-topicid="8428" href="/d/drug information/8428.html" rel="external">etomidate</a> to induce anesthesia during the acute resuscitative (ebb) phase, together with a small opioid dose. Induction anesthetics are administered cautiously (ie, slow administration in reduced doses) to avoid hypotension. (See <a class="local">'Induction'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Succinylcholine</strong> – <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">Succinylcholine</a> administration during the first 48 hours following a major burn is likely safe but should be avoided thereafter due to risk of life-threatening arrhythmias. (See <a class="local">'Use of succinylcholine'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Use of nondepolarizing neuromuscular blocking agents (NMBAs) </strong>–<strong> </strong>Since resistance to NMBAs is common following an acute burn injury, we increase the dose of <a class="drug drug_general" data-topicid="9872" href="/d/drug information/9872.html" rel="external">rocuronium</a> for rapid sequence induction and intubation (RSII) to 1.5mg/kg. Subsequently, redosing is likely to be necessary more frequently than for patients without burn injuries. (See <a class="local">'Use of nondepolarizing neuromuscular blockading agents'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Maintenance </strong>– During anesthetic maintenance, we typically select an inhalation-based or a "balanced," technique (employing an inhalation anesthetic, opioid, and NMBA). (See <a class="local">'Choice of maintenance technique'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Opioids </strong>– Opioid doses are reduced during the acute resuscitative (ebb) phase, then requirements are increased in the recovery (flow) and post-resuscitation phases. (See <a class="local">'Use of intraoperative opioids'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Local and regional anesthesia </strong>– Local and regional anesthetic techniques provide supplemental intraoperative analgesia and may improve postoperative analgesia to decrease opioid requirements. Regional approaches should target split thickness donor sites. (See <a class="local">'Use of local and regional anesthesia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fluid and transfusion management</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Crystalloid administration </strong>– (See <a class="local">'Fluid administration'</a> above and  <a class="medical medical_review" href="/d/html/350.html" rel="external">"Emergency care of moderate and severe thermal burns in adults", section on 'Estimating initial fluid requirements'</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>During the resuscitation phase, crystalloid solutions are administered. Some institutions administer hypertonic or colloid solutions (eg, albumin, fresh frozen plasma [FFP]), particularly if patients have inadequate urine output or evidence of poor perfusion.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>During early excisions, intraoperative volume losses are added to formula-guided (eg, Parkland formula) resuscitative fluid volume.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>During later procedures, volume administration depends on procedure-related considerations.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Transfusion decisions</strong> – We employ a restrictive transfusion strategy in hemodynamically stable patients without massive blood loss, with transfusion of a unit of packed red blood cells (RBCs) at a hemoglobin transfusion threshold of &lt;7 to 8 g/dL (hematocrit &lt;21 to 24 percent). (See <a class="local">'Transfusion decisions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemodynamic management </strong>– If profound hypotension or signs of tissue hypoperfusion develop, we administer vasoactive and/or inotropic agents as necessary. However, these agents may have local adverse effects on the injured skin and on skin grafts. (See <a class="local">'Hemodynamic management'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Temperature management </strong>– Prevent intraoperative hypothermia by using convective warming devices (ie, forced air warmers), administering warmed intravenous (IV) fluids, maintaining a warm ambient room temperature ≥25°C, and minimizing exposed body surface area. (See <a class="local">'Temperature management'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postoperative management</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Mechanical ventilation</strong> – The need for postoperative mechanical ventilation requirements is common in patients with severe burn injuries. (See <a class="local">'Use of mechanical ventilation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pain management </strong>– We utilize a multimodal opioid-sparing techniques including nonopioid analgesics (eg, <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a>, <a class="drug drug_general" data-topicid="8897" href="/d/drug information/8897.html" rel="external">dexmedetomidine</a>) and local or regional anesthetic techniques when feasible. (See <a class="local">'Challenges in pain management'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Later scar revision procedures </strong>– Scar revision procedures may be performed weeks or years after the initial burn injury. Airway management may be difficult due to skin contractures of the neck and mouth. (See <a class="local">'Later scar revision procedures'</a> above.)</p><p></p><p class="headingAnchor" id="H3075226406"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Sam Sharar, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Joffe AM, Aziz MF, Posner KL, et al. Management of Difficult Tracheal Intubation: A Closed Claims Analysis. Anesthesiology 2019; 131:818.</a></li><li><a class="nounderline abstract_t">Kleine-Brueggeney M, Greif R, Schoettker P, et al. Evaluation of six videolaryngoscopes in 720 patients with a simulated difficult airway: a multicentre randomized controlled trial. Br J Anaesth 2016; 116:670.</a></li><li><a class="nounderline abstract_t">Latenser BA. Critical care of the burn patient: the first 48 hours. Crit Care Med 2009; 37:2819.</a></li><li><a class="nounderline abstract_t">Bittner EA, Shank E, Woodson L, Martyn JA. Acute and perioperative care of the burn-injured patient. Anesthesiology 2015; 122:448.</a></li><li><a class="nounderline abstract_t">Crum RL, Dominic W, Hansbrough JF, et al. Cardiovascular and neurohumoral responses following burn injury. Arch Surg 1990; 125:1065.</a></li><li><a class="nounderline abstract_t">MacLennan N, Heimbach DM, Cullen BF. Anesthesia for major thermal injury. Anesthesiology 1998; 89:749.</a></li><li><a class="nounderline abstract_t">Abu-Sittah GS, Sarhane KA, Dibo SA, Ibrahim A. Cardiovascular dysfunction in burns: review of the literature. Ann Burns Fire Disasters 2012; 25:26.</a></li><li><a class="nounderline abstract_t">Williams FN, Herndon DN, Kulp GA, Jeschke MG. Propranolol decreases cardiac work in a dose-dependent manner in severely burned children. Surgery 2011; 149:231.</a></li><li><a class="nounderline abstract_t">Williams FN, Herndon DN, Suman OE, et al. Changes in cardiac physiology after severe burn injury. J Burn Care Res 2011; 32:269.</a></li><li><a class="nounderline abstract_t">Kumar P. Grading of severity of the condition in burn patients by serum protein and albumin/globulin studies. Ann Plast Surg 2010; 65:74.</a></li><li><a class="nounderline abstract_t">Kumar P, D'Souza J, Bhaskara KG, Bharadwaj S. Serum protein level in conjunction with serum albumin/globulin ratio as an indicator of severity of changes in capillary permeability. Burns 2003; 29:628.</a></li><li><a class="nounderline abstract_t">Pham TN, Cancio LC, Gibran NS, American Burn Association. American Burn Association practice guidelines burn shock resuscitation. J Burn Care Res 2008; 29:257.</a></li><li><a class="nounderline abstract_t">Soussi S, Berger MM, Colpaert K, et al. Hemodynamic management of critically ill burn patients: an international survey. Crit Care 2018; 22:194.</a></li><li><a class="nounderline abstract_t">Endorf FW, Dries DJ. Burn resuscitation. Scand J Trauma Resusc Emerg Med 2011; 19:69.</a></li><li><a class="nounderline abstract_t">Pruitt BA Jr. Protection from excessive resuscitation: "pushing the pendulum back". J Trauma 2000; 49:567.</a></li><li><a class="nounderline abstract_t">Cartotto R, Greenhalgh DG, Cancio C. Burn State of the Science: Fluid Resuscitation. J Burn Care Res 2017; 38:e596.</a></li><li><a class="nounderline abstract_t">Dai NT, Chen TM, Cheng TY, et al. The comparison of early fluid therapy in extensive flame burns between inhalation and noninhalation injuries. Burns 1998; 24:671.</a></li><li><a class="nounderline abstract_t">Suzuki M, Aikawa N, Kobayashi K, Higuchi R. Prognostic implications of inhalation injury in burn patients in Tokyo. Burns 2005; 31:331.</a></li><li><a class="nounderline abstract_t">Enkhbaatar P, Pruitt BA Jr, Suman O, et al. Pathophysiology, research challenges, and clinical management of smoke inhalation injury. Lancet 2016; 388:1437.</a></li><li><a class="nounderline abstract_t">Nakstad ER, Aass HCD, Opdahl H, et al. Bronchial wheezing predicts inflammation and respiratory failure in fire smoke victims. Acta Anaesthesiol Scand 2017; 61:1142.</a></li><li><a class="nounderline abstract_t">Palmieri TL. Use of beta-agonists in inhalation injury. J Burn Care Res 2009; 30:156.</a></li><li><a class="nounderline abstract_t">Rehberg S, Maybauer MO, Enkhbaatar P, et al. Pathophysiology, management and treatment of smoke inhalation injury. Expert Rev Respir Med 2009; 3:283.</a></li><li><a class="nounderline abstract_t">Liffner G, Bak Z, Reske A, Sjöberg F. Inhalation injury assessed by score does not contribute to the development of acute respiratory distress syndrome in burn victims. Burns 2005; 31:263.</a></li><li><a class="nounderline abstract_t">Boots RJ, Dulhunty JM, Paratz J, Lipman J. Respiratory Complications in Burns: An Evolving Spectrum of Injury. Clinical Pulmonary Medicine 2009; 16:16.</a></li><li><a class="nounderline abstract_t">Jenkins ME, Gottschlich MM, Warden GD. Enteral feeding during operative procedures in thermal injuries. J Burn Care Rehabil 1994; 15:199.</a></li><li><a class="nounderline abstract_t">Evans DC, Martindale RG, Kiraly LN, Jones CM. Nutrition optimization prior to surgery. Nutr Clin Pract 2014; 29:10.</a></li><li><a class="nounderline abstract_t">Hudson AS, Morzycki AD, Wong J. Safety and Benefits of Intraoperative Enteral Nutrition in Critically Ill Pediatric Burn Patients: A Systematic Review and Pooled Analysis. J Burn Care Res 2022; 43:1343.</a></li><li><a class="nounderline abstract_t">Lawton G, Dheansa B. The management of major burns – a surgical perspective. Current Anaesthesia &amp; Critical Care 2008; 19:275.</a></li><li><a class="nounderline abstract_t">Papini R. Management of burn injuries of various depths. BMJ 2004; 329:158.</a></li><li><a class="nounderline abstract_t">Griggs C, Goverman J, Bittner EA, Levi B. Sedation and Pain Management in Burn Patients. Clin Plast Surg 2017; 44:535.</a></li><li class="breakAll">American Society of Anesthesiologists. Standards for Basic Anesthetic Monitoring. Available at: http://www.asahq.org/~/media/For%20Members/documents/Standards%20Guidelines%20Stmts/Basic%20Anesthetic%20Monitoring%202011.ashx (Accessed on September 03, 2014).</li><li><a class="nounderline abstract_t">Lavrentieva A, Palmieri T. Determination of cardiovascular parameters in burn patients using arterial waveform analysis: a review. Burns 2011; 37:196.</a></li><li><a class="nounderline abstract_t">Thiele RH, Colquhoun DA, Blum FE, Durieux ME. The ability of anesthesia providers to visually estimate systolic pressure variability using the "eyeball" technique. Anesth Analg 2012; 115:176.</a></li><li><a class="nounderline abstract_t">Zhang C. Does the Device Matter in Goal-Directed Fluid Therapy? Anesth Analg 2016; 123:1061.</a></li><li><a class="nounderline abstract_t">Etherington L, Saffle J, Cochran A. Use of transesophageal echocardiography in burns:a retrospective review. J Burn Care Res 2010; 31:36.</a></li><li><a class="nounderline abstract_t">American Society of Anesthesiologists and Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology 2010; 112:1084.</a></li><li><a class="nounderline abstract_t">Holm C, Hörbrand F, Mayr M, et al. Acute hyperglycaemia following thermal injury: friend or foe? Resuscitation 2004; 60:71.</a></li><li><a class="nounderline abstract_t">Mecott GA, Al-Mousawi AM, Gauglitz GG, et al. The role of hyperglycemia in burned patients: evidence-based studies. Shock 2010; 33:5.</a></li><li><a class="nounderline abstract_t">Ray JJ, Meizoso JP, Allen CJ, et al. Admission Hyperglycemia Predicts Infectious Complications After Burns. J Burn Care Res 2017; 38:85.</a></li><li><a class="nounderline abstract_t">Kaiser HE, Kim CM, Sharar SR, Olivar HP. Advances in Perioperative and Critical Care of the Burn Patient. Advances in Anesthesia 2013; 31:137.</a></li><li><a class="nounderline abstract_t">Apfelbaum JL, Hagberg CA, Connis RT, et al. 2022 American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway. Anesthesiology 2022; 136:31.</a></li><li><a class="nounderline abstract_t">Botts J, Srivastava KA, Matsuda T, Hanumadass ML. Wire Fixation Of Endotracheal Tube For Surgery Of Severe Facial Burns. Annals of Burns and Fire Disasters 1998; 11.</a></li><li><a class="nounderline abstract_t">Sorbello M, Frova G. Frova introducer: neither a stylet nor simply an introducer. Anaesthesia 2008; 63:1010.</a></li><li><a class="nounderline abstract_t">Gray RM, Rode H. Intra-operative endotracheal tube stabilisation for facial burns. Burns 2010; 36:572.</a></li><li><a class="nounderline abstract_t">Assi P, Quiroga L, Gerold K, Caffrey J. Endotracheal Tube Fixation in Patients With Facial Burns, What Are the Options? Eplasty 2018; 18:ic19.</a></li><li><a class="nounderline abstract_t">Dillon JK, Bhat A, Barnes C, et al. Oral Endotracheal Tube Stabilization for Facial Burns in Infants-Report of Two Techniques. J Burn Care Res 2023; 44:992.</a></li><li><a class="nounderline abstract_t">Yamashita S, Kaneda K, Han TH. Population pharmacokinetics of a propofol bolus administered in patients with major burns. Burns 2010; 36:1215.</a></li><li><a class="nounderline abstract_t">Kaneda K, Han TH. Comparative population pharmacokinetics of fentanyl using non-linear mixed effect modeling: burns vs. non-burns. Burns 2009; 35:790.</a></li><li><a class="nounderline abstract_t">Han T, Kim H, Bae J, et al. Neuromuscular pharmacodynamics of rocuronium in patients with major burns. Anesth Analg 2004; 99:386.</a></li><li><a class="nounderline abstract_t">Blanchet B, Jullien V, Vinsonneau C, Tod M. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients. Clin Pharmacokinet 2008; 47:635.</a></li><li><a class="nounderline abstract_t">Shafer SL. Shock values. Anesthesiology 2004; 101:567.</a></li><li><a class="nounderline abstract_t">Dennis CJ, Chung KK, Holland SR, et al. Risk factors for hypotension in urgently intubated burn patients. Burns 2012; 38:1181.</a></li><li><a class="nounderline abstract_t">Pandit JJ. Intravenous anaesthetic agents. Anaesthesia and Intensive Care Medicine 2007; 9:154.</a></li><li><a class="nounderline abstract_t">Das S, Forrest K, Howell S. General anaesthesia in elderly patients with cardiovascular disorders: choice of anaesthetic agent. Drugs Aging 2010; 27:265.</a></li><li><a class="nounderline abstract_t">Jabre P, Combes X, Lapostolle F, et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet 2009; 374:293.</a></li><li><a class="nounderline abstract_t">Lipiner-Friedman D, Sprung CL, Laterre PF, et al. Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med 2007; 35:1012.</a></li><li><a class="nounderline abstract_t">Chan CM, Mitchell AL, Shorr AF. Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis*. Crit Care Med 2012; 40:2945.</a></li><li><a class="nounderline abstract_t">Lundy JB, Slane ML, Frizzi JD. Acute adrenal insufficiency after a single dose of etomidate. J Intensive Care Med 2007; 22:111.</a></li><li><a class="nounderline abstract_t">Komatsu R, You J, Mascha EJ, et al. Anesthetic induction with etomidate, rather than propofol, is associated with increased 30-day mortality and cardiovascular morbidity after noncardiac surgery. Anesth Analg 2013; 117:1329.</a></li><li><a class="nounderline abstract_t">McPhee LC, Badawi O, Fraser GL, et al. Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis: analysis of a large electronic ICU database. Crit Care Med 2013; 41:774.</a></li><li><a class="nounderline abstract_t">Johnson KB, Egan TD, Kern SE, et al. Influence of hemorrhagic shock followed by crystalloid resuscitation on propofol: a pharmacokinetic and pharmacodynamic analysis. Anesthesiology 2004; 101:647.</a></li><li><a class="nounderline abstract_t">Han TH, Lee JH, Kwak IS, et al. The relationship between bispectral index and targeted propofol concentration is biphasic in patients with major burns. Acta Anaesthesiol Scand 2005; 49:85.</a></li><li><a class="nounderline abstract_t">Han TH, Greenblatt DJ, Martyn JA. Propofol clearance and volume of distribution are increased in patients with major burns. J Clin Pharmacol 2009; 49:768.</a></li><li><a class="nounderline abstract_t">Martyn JA, Richtsfeld M. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology 2006; 104:158.</a></li><li><a class="nounderline abstract_t">Osta WA, El-Osta MA, Pezhman EA, et al. Nicotinic acetylcholine receptor gene expression is altered in burn patients. Anesth Analg 2010; 110:1355.</a></li><li><a class="nounderline abstract_t">Martyn JJA. Succinylcholine hyperkalemia after burns. Anesthesiology 1999; 91:321.</a></li><li><a class="nounderline abstract_t">Dwersteg JF, Pavlin EG, Heimbach DM. Patients with burns are resistant to atracurium. Anesthesiology 1986; 65:517.</a></li><li><a class="nounderline abstract_t">Martyn J. Clinical pharmacology and drug therapy in the burned patient. Anesthesiology 1986; 65:67.</a></li><li><a class="nounderline abstract_t">Han TH, Martyn JA. Onset and effectiveness of rocuronium for rapid onset of paralysis in patients with major burns: priming or large bolus. Br J Anaesth 2009; 102:55.</a></li><li><a class="nounderline abstract_t">Marathe PH, Dwersteg JF, Pavlin EG, et al. Effect of thermal injury on the pharmacokinetics and pharmacodynamics of atracurium in humans. Anesthesiology 1989; 70:752.</a></li><li class="breakAll">Capan LM, Miller SM, Gingrich KJ.. Trauma and Burns. In: Clinical Anesthesia, Seventh, Barash PG (Ed), Lippincott Williams &amp; Wilkins, Philadelphia 2013. p.1522.</li><li><a class="nounderline abstract_t">Cancio LC, Cuenca PB, Walker SC, Shepherd JM. Total intravenous anesthesia for major burn surgery. Int J Burns Trauma 2013; 3:108.</a></li><li><a class="nounderline abstract_t">Steinvall I, Fredrikson M, Bak Z, Sjoberg F. Incidence of early burn-induced effects on liver function as reflected by the plasma disappearance rate of indocyanine green: a prospective descriptive cohort study. Burns 2012; 38:214.</a></li><li><a class="nounderline abstract_t">Bussolin L, Busoni P, Giorgi L, et al. Tumescent local anesthesia for the surgical treatment of burns and postburn sequelae in pediatric patients. Anesthesiology 2003; 99:1371.</a></li><li><a class="nounderline abstract_t">Fujita K, Mishima Y, Iwasawa M, Matsuo K. The practical procedure of tumescent technique in burn surgery for excision of burn eschar. J Burn Care Res 2008; 29:924.</a></li><li><a class="nounderline abstract_t">Gümüş N. Tumescent infiltration of lidocaine and adrenaline for burn surgery. Ann Burns Fire Disasters 2011; 24:144.</a></li><li><a class="nounderline abstract_t">Greenhalgh DG. Management of Burns. N Engl J Med 2019; 380:2349.</a></li><li><a class="nounderline abstract_t">Hernandez JL, Savetamal A, Crombie RE, et al. Use of continuous local anesthetic infusion in the management of postoperative split-thickness skin graft donor site pain. J Burn Care Res 2013; 34:e257.</a></li><li><a class="nounderline abstract_t">Abdelrahman I, Steinvall I, Elmasry M, Sjoberg F. Lidocaine infusion has a 25% opioid-sparing effect on background pain after burns: A prospective, randomised, double-blind, controlled trial. Burns 2020; 46:465.</a></li><li><a class="nounderline abstract_t">Sheckter CC, Stewart BT, Barnes C, et al. Techniques and strategies for regional anesthesia in acute burn care-a narrative review. Burns Trauma 2021; 9:tkab015.</a></li><li><a class="nounderline abstract_t">Guilabert P, Usúa G, Martín N, et al. Fluid resuscitation management in patients with burns: update. Br J Anaesth 2016; 117:284.</a></li><li class="breakAll">Advanced burn life support course. American Burn Association. https://ameriburn.org/wp-content/uploads/2019/08/2018-abls-providermanual.pdf (Accessed on August 28, 2023).</li><li><a class="nounderline abstract_t">Navickis RJ, Greenhalgh DG, Wilkes MM. Albumin in Burn Shock Resuscitation: A Meta-Analysis of Controlled Clinical Studies. J Burn Care Res 2016; 37:e268.</a></li><li><a class="nounderline abstract_t">Palmieri TL, Greenhalgh DG. Blood transfusion in burns: what do we do? J Burn Care Rehabil 2004; 25:71.</a></li><li><a class="nounderline abstract_t">Palmieri TL, Holmes JH 4th, Arnoldo B, et al. Transfusion Requirement in Burn Care Evaluation (TRIBE): A Multicenter Randomized Prospective Trial of Blood Transfusion in Major Burn Injury. Ann Surg 2017; 266:595.</a></li><li><a class="nounderline abstract_t">Kwan P, Gomez M, Cartotto R. Safe and successful restriction of transfusion in burn patients. J Burn Care Res 2006; 27:826.</a></li><li><a class="nounderline abstract_t">Palmieri TL, Caruso DM, Foster KN, et al. Effect of blood transfusion on outcome after major burn injury: a multicenter study. Crit Care Med 2006; 34:1602.</a></li><li><a class="nounderline abstract_t">Higgins S, Fowler R, Callum J, Cartotto R. Transfusion-related acute lung injury in patients with burns. J Burn Care Res 2007; 28:56.</a></li><li><a class="nounderline abstract_t">Budny PG, Regan PJ, Roberts AH. The estimation of blood loss during burns surgery. Burns 1993; 19:134.</a></li><li><a class="nounderline abstract_t">Housinger TA, Lang D, Warden GD. A prospective study of blood loss with excisional therapy in pediatric burn patients. J Trauma 1993; 34:262.</a></li><li><a class="nounderline abstract_t">Cartotto R, Musgrave MA, Beveridge M, et al. Minimizing blood loss in burn surgery. J Trauma 2000; 49:1034.</a></li><li><a class="nounderline abstract_t">O'Mara MS, Hayetian F, Slater H, et al. Results of a protocol of transfusion threshold and surgical technique on transfusion requirements in burn patients. Burns 2005; 31:558.</a></li><li><a class="nounderline abstract_t">Papp AA, Uusaro AV, Ruokonen ET. The effects of topical epinephrine on haemodynamics and markers of tissue perfusion in burned and non-burned patients requiring skin grafting. Burns 2009; 35:832.</a></li><li><a class="nounderline abstract_t">McQuitty CK, Berman J, Cortiella J, et al. beta-adrenergic desensitization after burn excision not affected by the use of epinephrine to limit blood loss. Anesthesiology 2000; 93:351.</a></li><li><a class="nounderline abstract_t">Missavage AE, Bush RL, Kien ND, Reilly DA. The effect of clysed and topical epinephrine on intraoperative catecholamine levels. J Trauma 1998; 45:1074.</a></li><li><a class="nounderline abstract_t">Cartotto R, Kadikar N, Musgrave MA, et al. What are the acute cardiovascular effects of subcutaneous and topical epinephrine for hemostasis during burn surgery? J Burn Care Rehabil 2003; 24:297.</a></li><li><a class="nounderline abstract_t">Mitchell RT, Funk D, Spiwak R, Logsetty S. Phenylephrine tumescence in split-thickness skin graft donor sites in surgery for burn injury- a concentration finding study. J Burn Care Res 2011; 32:129.</a></li><li><a class="nounderline abstract_t">Mullins F, Mian MA, Jenkins D, et al. Thromboembolic complications in burn patients and associated risk factors. J Burn Care Res 2013; 34:355.</a></li><li><a class="nounderline abstract_t">Pannucci CJ, Osborne NH, Wahl WL. Venous thromboembolism in thermally injured patients: analysis of the National Burn Repository. J Burn Care Res 2011; 32:6.</a></li><li><a class="nounderline abstract_t">Domínguez A, Alsina E, Landín L, et al. Transfusion requirements in burn patients undergoing primary wound excision: effect of tranexamic acid. Minerva Anestesiol 2017; 83:353.</a></li><li><a class="nounderline abstract_t">Bhatia N, Sen I, Kumari K, et al. Impact of single dose intravenous tranexamic acid on peri-operative blood transfusion requirements in burn patients: A prospective, randomized trial. Egyptian Journal of Anaesthesia 2017; 33:251.</a></li><li><a class="nounderline abstract_t">Fijany AJ, Givechian KB, Zago I, et al. Tranexamic acid in burn surgery: A systematic review and meta-analysis. Burns 2023; 49:1249.</a></li><li><a class="nounderline abstract_t">Johansson PI, Eriksen K, Nielsen SL, et al. Recombinant FVIIa decreases perioperative blood transfusion requirement in burn patients undergoing excision and skin grafting--results of a single centre pilot study. Burns 2007; 33:435.</a></li><li><a class="nounderline abstract_t">Simpson E, Lin Y, Stanworth S, et al. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2012; :CD005011.</a></li><li><a class="nounderline abstract_t">Glas GJ, Levi M, Schultz MJ. Coagulopathy and its management in patients with severe burns. J Thromb Haemost 2016; 14:865.</a></li><li><a class="nounderline abstract_t">Lu RP, Ni A, Lin FC, et al. Major burn injury is not associated with acute traumatic coagulopathy. J Trauma Acute Care Surg 2013; 74:1474.</a></li><li><a class="nounderline abstract_t">Palmieri TL, Greenhalgh DG, Sen S. Prospective comparison of packed red blood cell-to-fresh frozen plasma transfusion ratio of 4: 1 versus 1: 1 during acute massive burn excision. J Trauma Acute Care Surg 2013; 74:76.</a></li><li><a class="nounderline abstract_t">Causbie J, Sattler L, Basel A, et al. State of the Art: An update on adult burn resuscitation. Eur Burn J 2021; 2:152.</a></li><li><a class="nounderline abstract_t">Knappskog K, Andersen NG, Guttormsen AB, et al. Vasoactive and/or inotropic drugs in initial resuscitation of burn injuries: A systematic review. Acta Anaesthesiol Scand 2022; 66:795.</a></li><li><a class="nounderline abstract_t">Sims CA, Holena D, Kim P, et al. Effect of Low-Dose Supplementation of Arginine Vasopressin on Need for Blood Product Transfusions in Patients With Trauma and Hemorrhagic Shock: A Randomized Clinical Trial. JAMA Surg 2019; 154:994.</a></li><li><a class="nounderline abstract_t">Hostler D, Weaver MD, Ziembicki JA, et al. Admission temperature and survival in patients admitted to burn centers. J Burn Care Res 2013; 34:498.</a></li><li><a class="nounderline abstract_t">Asmussen S, Maybauer DM, Fraser JF, et al. Extracorporeal membrane oxygenation in burn and smoke inhalation injury. Burns 2013; 39:429.</a></li><li><a class="nounderline abstract_t">Askegard-Giesmann JR, Besner GE, Fabia R, et al. Extracorporeal membrane oxygenation as a lifesaving modality in the treatment of pediatric patients with burns and respiratory failure. J Pediatr Surg 2010; 45:1330.</a></li><li><a class="nounderline abstract_t">Heng X, Cai P, Yuan Z, et al. Efficacy and safety of extracorporeal membrane oxygenation for burn patients: a comprehensive systematic review and meta-analysis. Burns Trauma 2023; 11:tkac056.</a></li><li><a class="nounderline abstract_t">Holtman JR Jr, Jellish WS. Opioid-induced hyperalgesia and burn pain. J Burn Care Res 2012; 33:692.</a></li><li><a class="nounderline abstract_t">Romanowski KS, Carson J, Pape K, et al. American Burn Association Guidelines on the Management of Acute Pain in the Adult Burn Patient: A Review of the Literature, a Compilation of Expert Opinion, and Next Steps. J Burn Care Res 2020; 41:1129.</a></li><li><a class="nounderline abstract_t">Jones GM, Porter K, Coffey R, et al. Impact of early methadone initiation in critically injured burn patients: a pilot study. J Burn Care Res 2013; 34:342.</a></li><li><a class="nounderline abstract_t">Williams PI, Sarginson RE, Ratcliffe JM. Use of methadone in the morphine-tolerant burned paediatric patient. Br J Anaesth 1998; 80:92.</a></li><li><a class="nounderline abstract_t">McGuinness SK, Wasiak J, Cleland H, et al. A systematic review of ketamine as an analgesic agent in adult burn injuries. Pain Med 2011; 12:1551.</a></li><li><a class="nounderline abstract_t">Edrich T, Friedrich AD, Eltzschig HK, Felbinger TW. Ketamine for long-term sedation and analgesia of a burn patient. Anesth Analg 2004; 99:893.</a></li><li><a class="nounderline abstract_t">Silverstein WK, Juurlink DN, Zipursky JS. Ketamine for the treatment of acute pain. CMAJ 2021; 193:E1663.</a></li><li><a class="nounderline abstract_t">Perumal DK, Adhimoolam M, Selvaraj N, et al. Midazolam premedication for Ketamine-induced emergence phenomenon: A prospective observational study. J Res Pharm Pract 2015; 4:89.</a></li><li><a class="nounderline abstract_t">Morris C, Perris A, Klein J, Mahoney P. Anaesthesia in haemodynamically compromised emergency patients: does ketamine represent the best choice of induction agent? Anaesthesia 2009; 64:532.</a></li><li><a class="nounderline abstract_t">Barrett W, Buxhoeveden M, Dhillon S. Ketamine: a versatile tool for anesthesia and analgesia. Curr Opin Anaesthesiol 2020; 33:633.</a></li><li><a class="nounderline abstract_t">Asmussen S, Maybauer DM, Fraser JF, et al. A meta-analysis of analgesic and sedative effects of dexmedetomidine in burn patients. Burns 2013; 39:625.</a></li><li><a class="nounderline abstract_t">Kharasch ED, Clark JD, Kheterpal S. Perioperative Gabapentinoids: Deflating the Bubble. Anesthesiology 2020; 133:251.</a></li><li><a class="nounderline abstract_t">Apfelbaum JL, Hagberg CA, Connis RT, et al. 2022 American Society of Anesthesiologists practice guidelines for management of the difficult airway. Anesthesiology 2021; (in press).</a></li></ol></div><div id="topicVersionRevision">Topic 94580 Version 26.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31584884" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Management of Difficult Tracheal Intubation: A Closed Claims Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27106971" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Evaluation of six videolaryngoscopes in 720 patients with a simulated difficult airway: a multicentre randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19707133" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Critical care of the burn patient: the first 48 hours.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25485468" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Acute and perioperative care of the burn-injured patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1974129" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Cardiovascular and neurohumoral responses following burn injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9743414" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Anesthesia for major thermal injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23012613" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Cardiovascular dysfunction in burns: review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20598332" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Propranolol decreases cardiac work in a dose-dependent manner in severely burned children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21228708" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Changes in cardiac physiology after severe burn injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20548219" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Grading of severity of the condition in burn patients by serum protein and albumin/globulin studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12927997" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Serum protein level in conjunction with serum albumin/globulin ratio as an indicator of severity of changes in capillary permeability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18182930" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : American Burn Association practice guidelines burn shock resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30115108" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Hemodynamic management of critically ill burn patients: an international survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22078326" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Burn resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11003341" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Protection from excessive resuscitation: "pushing the pendulum back".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28328669" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Burn State of the Science: Fluid Resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9882069" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The comparison of early fluid therapy in extensive flame burns between inhalation and noninhalation injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15774289" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Prognostic implications of inhalation injury in burn patients in Tokyo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27707500" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Pathophysiology, research challenges, and clinical management of smoke inhalation injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28832892" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Bronchial wheezing predicts inflammation and respiratory failure in fire smoke victims.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19060734" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Use of beta-agonists in inhalation injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20161170" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Pathophysiology, management and treatment of smoke inhalation injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15774279" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Inhalation injury assessed by score does not contribute to the development of acute respiratory distress syndrome in burn victims.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Respiratory Complications in Burns: An Evolving Spectrum of Injury</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8195265" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Enteral feeding during operative procedures in thermal injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24347529" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Nutrition optimization prior to surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35304893" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Safety and Benefits of Intraoperative Enteral Nutrition in Critically Ill Pediatric Burn Patients: A Systematic Review and Pooled Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The management of major burns–a surgical perspective</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15258073" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Management of burn injuries of various depths.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28576242" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Sedation and Pain Management in Burn Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28576242" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Sedation and Pain Management in Burn Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21130581" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Determination of cardiovascular parameters in burn patients using arterial waveform analysis: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22467895" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The ability of anesthesia providers to visually estimate systolic pressure variability using the "eyeball" technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27636581" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Does the Device Matter in Goal-Directed Fluid Therapy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20061835" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Use of transesophageal echocardiography in burns:a retrospective review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20418689" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14987787" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Acute hyperglycaemia following thermal injury: friend or foe?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19503020" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The role of hyperglycemia in burned patients: evidence-based studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27355659" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Admission Hyperglycemia Predicts Infectious Complications After Burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Advances in Perioperative and Critical Care of the Burn Patient</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34762729" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : 2022 American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Wire Fixation Of Endotracheal Tube For Surgery Of Severe Facial Burns</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18699874" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Frova introducer: neither a stylet nor simply an introducer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20061089" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Intra-operative endotracheal tube stabilisation for facial burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30344841" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Endotracheal Tube Fixation in Patients With Facial Burns, What Are the Options?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37232409" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Oral Endotracheal Tube Stabilization for Facial Burns in Infants-Report of Two Techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20510522" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Population pharmacokinetics of a propofol bolus administered in patients with major burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19501972" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Comparative population pharmacokinetics of fentanyl using non-linear mixed effect modeling: burns vs. non-burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15271712" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Neuromuscular pharmacodynamics of rocuronium in patients with major burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18783295" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15329579" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Shock values.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22884966" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Risk factors for hypotension in urgently intubated burn patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Intravenous anaesthetic agents</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20359259" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : General anaesthesia in elderly patients with cardiovascular disorders: choice of anaesthetic agent.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19573904" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17334243" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Adrenal function in sepsis: the retrospective Corticus cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22971586" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis*.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17456730" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Acute adrenal insufficiency after a single dose of etomidate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24257383" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Anesthetic induction with etomidate, rather than propofol, is associated with increased 30-day mortality and cardiovascular morbidity after noncardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23318491" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis: analysis of a large electronic ICU database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15329589" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Influence of hemorrhagic shock followed by crystalloid resuscitation on propofol: a pharmacokinetic and pharmacodynamic analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15675988" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : The relationship between bispectral index and targeted propofol concentration is biphasic in patients with major burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19553403" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Propofol clearance and volume of distribution are increased in patients with major burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16394702" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20304984" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Nicotinic acetylcholine receptor gene expression is altered in burn patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Succinylcholine hyperkalemia after burns</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3777482" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Patients with burns are resistant to atracurium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2873763" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Clinical pharmacology and drug therapy in the burned patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19029093" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Onset and effectiveness of rocuronium for rapid onset of paralysis in patients with major burns: priming or large bolus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2719307" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Effect of thermal injury on the pharmacokinetics and pharmacodynamics of atracurium in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2719307" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Effect of thermal injury on the pharmacokinetics and pharmacodynamics of atracurium in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23638329" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Total intravenous anesthesia for major burn surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22040928" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Incidence of early burn-induced effects on liver function as reflected by the plasma disappearance rate of indocyanine green: a prospective descriptive cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14639151" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Tumescent local anesthesia for the surgical treatment of burns and postburn sequelae in pediatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18849848" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : The practical procedure of tumescent technique in burn surgery for excision of burn eschar.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22396674" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Tumescent infiltration of lidocaine and adrenaline for burn surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31189038" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Management of Burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23271060" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Use of continuous local anesthetic infusion in the management of postoperative split-thickness skin graft donor site pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31493952" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Lidocaine infusion has a 25% opioid-sparing effect on background pain after burns: A prospective, randomised, double-blind, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34285927" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Techniques and strategies for regional anesthesia in acute burn care-a narrative review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27543523" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Fluid resuscitation management in patients with burns: update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27543523" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Fluid resuscitation management in patients with burns: update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25426807" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Albumin in Burn Shock Resuscitation: A Meta-Analysis of Controlled Clinical Studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14726742" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Blood transfusion in burns: what do we do?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28697050" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Transfusion Requirement in Burn Care Evaluation (TRIBE): A Multicenter Randomized Prospective Trial of Blood Transfusion in Major Burn Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17091078" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Safe and successful restriction of transfusion in burn patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16607231" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Effect of blood transfusion on outcome after major burn injury: a multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17211201" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Transfusion-related acute lung injury in patients with burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8471147" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : The estimation of blood loss during burns surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8459467" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : A prospective study of blood loss with excisional therapy in pediatric burn patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11130485" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Minimizing blood loss in burn surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15955634" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Results of a protocol of transfusion threshold and surgical technique on transfusion requirements in burn patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19481869" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : The effects of topical epinephrine on haemodynamics and markers of tissue perfusion in burned and non-burned patients requiring skin grafting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10910481" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : beta-adrenergic desensitization after burn excision not affected by the use of epinephrine to limit blood loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9867051" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : The effect of clysed and topical epinephrine on intraoperative catecholamine levels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14501398" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : What are the acute cardiovascular effects of subcutaneous and topical epinephrine for hemostasis during burn surgery?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21131843" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Phenylephrine tumescence in split-thickness skin graft donor sites in surgery for burn injury- a concentration finding study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23624995" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Thromboembolic complications in burn patients and associated risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21127423" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Venous thromboembolism in thermally injured patients: analysis of the National Burn Repository.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27827518" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Transfusion requirements in burn patients undergoing primary wound excision: effect of tranexamic acid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Impact of single dose intravenous tranexamic acid on peri-operative blood transfusion requirements in burn patients: A prospective, randomized trial</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37268542" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Tranexamic acid in burn surgery: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17382476" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Recombinant FVIIa decreases perioperative blood transfusion requirement in burn patients undergoing excision and skin grafting--results of a single centre pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22419303" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26854881" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Coagulopathy and its management in patients with severe burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23694874" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Major burn injury is not associated with acute traumatic coagulopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23271080" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Prospective comparison of packed red blood cell-to-fresh frozen plasma transfusion ratio of 4: 1 versus 1: 1 during acute massive burn excision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : State of the Art: An update on adult burn resuscitation</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35583993" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Vasoactive and/or inotropic drugs in initial resuscitation of burn injuries: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31461138" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Effect of Low-Dose Supplementation of Arginine Vasopressin on Need for Blood Product Transfusions in Patients With Trauma and Hemorrhagic Shock: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23966115" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Admission temperature and survival in patients admitted to burn centers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23062623" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Extracorporeal membrane oxygenation in burn and smoke inhalation injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20620340" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Extracorporeal membrane oxygenation as a lifesaving modality in the treatment of pediatric patients with burns and respiratory failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36873286" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Efficacy and safety of extracorporeal membrane oxygenation for burn patients: a comprehensive systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23143613" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Opioid-induced hyperalgesia and burn pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32885244" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : American Burn Association Guidelines on the Management of Acute Pain in the Adult Burn Patient: A Review of the Literature, a Compilation of Expert Opinion, and Next Steps.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23079564" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Impact of early methadone initiation in critically injured burn patients: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9505787" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Use of methadone in the morphine-tolerant burned paediatric patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21880111" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : A systematic review of ketamine as an analgesic agent in adult burn injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15333427" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Ketamine for long-term sedation and analgesia of a burn patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34725114" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Ketamine for the treatment of acute pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25984547" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Midazolam premedication for Ketamine-induced emergence phenomenon: A prospective observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19413824" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Anaesthesia in haemodynamically compromised emergency patients: does ketamine represent the best choice of induction agent?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32826629" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Ketamine: a versatile tool for anesthesia and analgesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23465796" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : A meta-analysis of analgesic and sedative effects of dexmedetomidine in burn patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32667153" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Perioperative Gabapentinoids: Deflating the Bubble.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : 2022 American Society of Anesthesiologists practice guidelines for management of the difficult airway</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
